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ABSTRACT 
Developmental exposure to aryl hydrocarbon receptor (AhR) agonists in fish causes 
severe defects in the cardiovascular system.  However, the effects of acute AhR agonist 
exposure on the adult fish cardiovascular system as well as the genes mediating 
developmental AhR-induced deformities remain unclear.  In this thesis, two studies were 
carried out to address these issues.  Before experiments could begin, methods for 
quantitative real-time reverse transcriptase polymerase chain reaction (rtrt-PCR) as well as 
larval exposure and rearing were developed, validated, and optimized.   
Following method development, a series of experiments was performed on adult 
zebrafish (Danio rerio) to assess how expression of cytochrome P450 (CYP) and 
cyclooxygenase (COX) enzyme mRNA in hepatic and vascular tissues is altered after 
intraperitoneal injection of AhR agonists benzo(a)pyrene (BaP) or 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) alone and in combination with the purported AhR 
antagonists resveratrol (Res) or α-naphthoflavone (ANF).  Both TCDD and BaP induced 
similar patterns of gene expression in arteries, although with different efficacies, and had 
slightly different effects in hepatic tissues.  Resveratrol was generally without effect in all 
treatment groups and tissues with the exception of reducing TCDD-induced CYP1C2 in 
vascular tissues.  In contrast, ANF antagonized TCDD- and BaP-induced changes, as well 
as reduced baseline gene expression in liver.  However, in arteries, ANF alone acted as an 
agonist to increase expression of several of the genes investigated. 
The second series of experiments involved zebrafish eggs aqueously exposed to 
BaP or TCDD alone and in combination with Res or ANF.  Whole larvae CYP and COX 
isoform mRNA expression was quantified at 5 and 10 days post-fertilization (dpf), then 
correlated with developmental phenotype.  Both TCDD and BaP caused concentration-
dependent AhR-associated deformities with a significant increase in mortalities by 10 dpf 
and increased CYP1A mRNA expression, while TCDD alone decreased CYP1C2 
expression.  BaP/ANF co-exposure exhibited the highest rate of deformities and mortalities 
at both 5 and 10 dpf, caused marked alterations in cardiac and vascular morphology at 10 
dpf, and increased CYP1A expression.  Furthermore, ANF exhibited additive agonistic 
effects on gene expression with both BaP and TCDD.  Correlation analyses revealed that 
 ii
gene expression at 5 dpf, but not 10 dpf, was strongly linked to abnormal cardiac and 
vascular phenotypes at 10 dpf with several genes related to cardiac development and one 
primary gene linked to vascular development. 
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1.0  INTRODUCTION 
 
1.1  Main Theme of Thesis 
 
 The major theme of this thesis is an exploration of the mechanisms of 
cardiovascular toxicity in fish produced by the common environmental contaminants, 
benzo(a)pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. After developing several methods 
needed for the main work of the thesis, the first study of this thesis examines effects of 
these contaminants when adult fish are acutely exposed. This is followed by another series 
of experiments examining effects of these contaminants after developmental exposure in 
fish.  
 
 
1.2  Aryl Hydrocarbon Receptor  
 
 The aryl hydrocarbon receptor (AhR) is a member of the PAS (Per/ARNT/ Sim) 
protein family which have a basic helix-loop-helix conformation.  While an endogenous 
antagonist, 7-ketocholesterol, has been found, there is no confirmed endogenous agonist, 
although several ligands are candidates including some arachidonic acid metabolites 
(Karchner et al., 1999; Andreasen et al., 2002a; Hahn, 2002; Nguyen and Bradfield, 2008).  
The AhR is a ligand-dependent cytosolic transcription factor which functions in mediating 
toxicological responses to various environmental contaminants, such as dioxins, 
benzo(a)pyrene, and polychlorinated biphenyls, which bind to AhR with high affinity 
(Andreasen et al., 2002a; Hahn, 2002; Denison and Nagy, 2003), while its role in normal 
development remains unclear.  In its non-liganded bound form, the AhR resides in the 
cytosol of a cell, complexed with two molecules of heat shock protein 90 (HSP90) and with 
an aryl hydrocarbon interacting protein (AIP), also known as the hepatitis B virus X-
associated protein (XAP-2) in mammals (Figure 1.1).  This complexation allows the AhR  
 
1 
  
 
 
 
 
 
 
 
 
Figure 1.1: Simplified schematic of the aryl hydrocarbon receptor mechanism of enzyme 
induction.  AHR – Aryl hydrocarbon receptor; HSP90 – heat shock protein; AIP – aryl 
hydrocarbon interacting protein; ARNT – AHR nuclear translocator; ER – endoplasmic 
reticulum; CYP1A – cytochrome P4501A 
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to remain in a viable conformation for ligand binding.  Once the AhR is bound by a ligand 
molecule, it translocates into the nucleus and dissociates from the chaperone proteins.  The 
AhR then forms a dimer with the aryl hydrocarbon receptor nuclear translocator (ARNT).  
This dimer then binds to specific DNA sequences termed dioxin-response elements (DRE) 
which are located in the 5’-regulatory region of DRE responsive genes (Denison and Nagy, 
2003).  The AhR battery of genes currently includes cytochrome P4501A dependent 
monooxygenases (CYP1A), CYP1B1, NADPH: oxidoreductase, aldehyde dehydrogenase, 
UDP glucuronosyltransferase, and glutathione s-transferase (Nebert et al., 2000), but the 
list continues to increase as more data becomes available.  There are many other genes 
currently under investigation for regulation by AhR, including CYP1C1 and CYP1C2, 
which appear to be exclusive to fish species (Godard et al., 2005; Wang et al., 2006; 
Jönsson et al., 2007a, b), as well as anti-angiogenic factors such as Angz, cardiac myosin 
isoforms, transforming growth factor β (TGF-β), and genes involved in cardiac cell cycle 
progression in fish (Bello et al., 2004; Handley-Goldstone et al., 2005; Carney et al., 2006).  
CYP1A and CYP1B1 expression has been shown to increase after AhR agonist exposure in 
the murine heart (Nebert et al., 2000) and in the zebrafish heart (Carney et al., 2006).  
Furthermore, CYP1A has been shown to be significantly active in both mammalian and 
fish vascular endothelial cells (Van Veld et al., 1997; Kerzee and Ramos, 2001; Dong et al., 
2002; Teraoka et al., 2002) and, to a much lesser extent, in vascular smooth muscle (Kerzee 
and Ramos, 2001) after AhR agonist exposure.  In contrast, CYP1B1 has significant 
expression in vascular smooth muscle but little in the endothelium (Kerzee and Ramos, 
2001) after AhR agonist exposure. 
 There is only one subtype of the AhR in mammals however in most fish species, 
there are at least two separate genes encoding AhR (Andreasen et al., 2002a, b; Karchner et 
al., 2005; Antkiewicz et al., 2006).  In zebrafish, three AhR genes, designated AHR1a, 
AHR1b, and AHR2, have been characterized (Karchner et al., 2005).  Sequence 
comparisons indicate that AHR1a in fish has significant sequence homology to mammalian 
AHR (Andreasen et al., 2002a).  Functionally, AHR2 (Andreasen et al., 2002a, b; Karchner 
et al., 2005; Antkiewicz et al., 2006) and AHR1b (Karchner et al., 2005) exhibit high-
affinity TCDD binding, whereas AHR1a appears to lack the ability to bind or be activated 
3 
by TCDD or related compounds (Andreasen et al., 2002a; Karchner et al., 2005).  The 
AHR1b gene binds to TCDD with lower affinity than does AHR2, but both may be 
involved in cell-specific CYP1A regulation in fish (Karchner et al., 2005).  Along with the 
three AHR genes, zebrafish also have two ARNT genes (ARNT1 and ARNT2) (Karchner 
et al., 2005; Antkiewicz et al., 2006).  Antkiewicz et al. (2006) showed that most, if not all 
toxic responses to TCDD exposure in zebrafish appear to be mediated by AHR2 and 
ARNT1.  Knocking down AHR2 or ARNT1 expression in zebrafish embryos appears to 
protect them from classic TCDD-induced developmental deformities including pericardial 
edema, lower jaw malformation, altered heart morphology, decreased stroke volume, and 
decreased cardiac output (Cantrell et al., 1998; Karchner et al., 2005; Antkiewicz et al., 
2006; Billiard et al., 2006). 
 
 
1.3  Benzo(a)pyrene 
 
 Benzo(a)pyrene (BaP) belongs to a family of compounds called polycyclic aromatic 
hydrocarbons (PAHs).  The PAHs are products of incomplete combustion and are found in 
petroleum products, coal tar, tobacco smoke, vehicle exhaust fumes, and charbroiled foods 
(Hattemer-Frey and Travis, 1991).  There has been an increase in PAH concentrations in 
aquatic environments around urban areas recently, thought to be associated with urban 
sprawl and global transport (Van Metre et al., 2000; Borghesi et al., 2008).  There is also 
evidence to indicate that PAHs from oil spills can remain in sediments at detectable levels 
for decades after the spill site has been decontaminated (Reddy et al., 2002).  Fish are 
exposed to BaP and other related compounds primarily through dietary means, gill uptake, 
or absorption in incubating eggs from contaminated sediments.  BaP is rapidly metabolized 
and produces toxic effects by activating the AhR, increasing transcription of the CYP1A 
and CYP1B1 genes (Shertzer et al., 2004).  Benzo(a)pyrene stimulates its own clearance 
from an organism by inducing CYP enzymes that metabolize it.  The metabolites produced 
by CYP activity on BaP are unstable (i.e. epoxides and quinones), and produce mutagenic 
and cytotoxic effects, as well as oxygen free radicals (Miller and Ramos, 2001).  Fish are 
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most susceptible during the developmental stages of their lifecycle and exposure to BaP 
during these stages leads to numerous physical deformities including dorsal curvature, 
difficulties with or failure of swim bladder inflation, and embryonic pericardial and yolk-
sac edema (Incardona et al., 2004).  However, the role of AhR stimulation compared to 
other mechanisms of PAH-mediated developmental defects remains unclear (Incardona et 
al., 2004). 
 
 
1.4  2,3,7,8-Tetrachlorodibenzo-p-dioxin 
 
 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin) belongs to the halogenated 
aromatic hydrocarbon (HAH) family of compounds.  TCDD has the highest potency and 
binding affinity for AhR of all the chemicals in this class (Mimura and Fujii-Kuriyama, 
2003).  Unlike PAHs, it is proposed that all adverse biological responses seen upon 
exposure to HAHs such as TCDD are caused by AhR activation and CYP induction 
(Cantrell et al., 1998; Bello et al., 2004; Antkiewicz et al., 2005).  Induction of CYP 
enzymes by TCDD has been shown to increase vascular permeability and vascular lesions 
(Cantrell et al., 1998; Guiney et al., 2000; Dong et al., 2002).  Unlike BaP, the 
metabolically stable TCDD does not induce its own metabolism although TCDD does bind 
to CYP substrate binding sites thereby preventing CYP action on other substrates and 
uncoupling the CYP-associated electron transport chain to produce oxygen free radicals 
(Schlezinger et al., 1999, 2000b).  Fish are highly sensitive to HAH toxicity, especially in 
the larval and developmental stages.  Vascular lesions that develop in the embryonic stage 
increase in severity during development, eventually resulting in decreased blood flow, 
vascular bed failure, and tissue necrosis (Henry et al., 1997; Cantrell et al., 1998; 
Andreasen et al., 2002b; Bello et al., 2004; Antkiewicz et al., 2005).  Zebrafish (used as a 
model species in this thesis) are a less sensitive species than lake trout or other salmonids 
but still develop characteristic symptoms of AhR-mediated toxicity (Antkiewicz et al., 
2005; Goldstone and Stegeman, 2006).  
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1.5  Cardiac Function and Development 
 
 Mammalian and fish hearts have similar forms.  Blood flows into the atrium from a 
major vein and then moves into the ventricle where it is delivered to the aorta (Thisse and 
Zon, 2002).  Cardiac valves form at atrial and ventricular boundaries to direct blood flow 
and ensure unidirectionality (Dooley and Zon, 2000; Thisse and Zon, 2002).  Compared to 
the four-chambered mammalian heart, the more primitive fish heart has only 2 chambers 
(Figure 1.2) (Thisse and Zon, 2002).  As blood exits the ventricle via the dorsal aorta, it is 
pumped over the gill arches where oxygenation occurs before the blood is distributed to the 
rest of the body (Hu et al., 2000).   
 Heart rate tends to vary with animal size, thus, smaller animals, such as zebrafish, 
have naturally fast heart rates (Hu et al., 2000, 2001).  There are several natural stressors 
that affect heart rate, such as temperature and oxygen fluctuations or predation.  Increased 
stress leads to the release of endogenous catecholamines epinephrine and norepinephrine 
which are known to increase heart rate in both mammals and fish (Eckstein et al., 1962; 
Cobb and Santer, 1973; Denvir et al., 2008). Likewise, the endogenous neurotransmitter 
acetylcholine decreases heart rate in both mammals and fish (Cobb and Santer, 1973; Yang 
et al., 1993).   
Regulation of cardiac function in adult fish lags behind in understanding compared 
to mammals. Furthermore, the point at which developing hearts become responsive to 
catecholamines and acetylcholine is unclear. There has been a consistent toxicological 
effect noted after developmental TCDD exposure in fish, namely decreased heart rate and 
cardiac output (Andreasen et al., 2002b; Antkiewicz et al., 2005; Carney et al., 2006; 
Yamauchi et al., 2006). However, whether this is due to a change in endogenous cardiac 
regulation, delayed development, or a structural change is unclear. 
 Normal cardiovascular development in zebrafish begins with the formation of a 
primitive heart tube composed of cardiac myocytes and endocardial endothelial cells 
(Figure 1.3; Nemer and Nemer, 2001).  This heart tube begins beating around 22 hours 
post-fertilization (hpf), with coordinated atrial and ventricular contractions coinciding with 
heart looping that occurs around 36 hpf (Dooley and Zon, 2000; Goldstone and Stegeman, 
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Figure 1.2: Diagram of the adult zebrafish heart (Hu et al., 2001; reproduced with 
permission from Wiley-Liss, Inc. a subsidiary of John Wiley & Sons, Inc.). 
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Figure 1.3: Time-line of normal zebrafish development from 0 to 120 hours post-
fertilization (hpf) and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on normal 
development.  CCV – common cardinal vein (Goldstone and Stegeman, 2006; reproduced 
with permission from Taylor & Francis). 
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2006).  Hatching occurs over the course of the third day after fertilization and definitive 
erythropoiesis occurs before the fourth day.  It is during these first 96 hours of development 
that exposure to chemicals such as TCDD can induce circulatory impairment (Belair et al., 
2001).  Signs of circulatory impairment begin to appear around 48 hpf with the reduction of 
common cardinal vein growth and subtle reductions in red blood cell perfusion rate in the 
brain and trunk (Dong et al., 2002; Teraoka et al., 2002; Bello et al., 2004).  While these 
initial indicators appear to involve only vasculature, there is a characteristic cardiac 
phenotype associated with circulatory impairment.  Before alterations in blood flow are 
apparent, the looping process of the heart is affected.  Normal looping occurs at 36 hpf, but 
developmental exposure to polycyclic and halogenated aromatic hydrocarbons result in 
poorly looped or unlooped hearts (Figure 1.4) which may be a major contributing factor to 
the eventual circulation failure that precedes mortality after exposure to these chemicals 
(Antkiewicz et al., 2006; Carney et al., 2006; Incardona et al., 2006). 
 
 
1.6  Vascular Function and Development 
 
 Arterial physiology shows many similarities in all vertebrates.  All artery walls are 
composed of three layers: a single layer of endothelial cells lining the vessel lumen, a layer 
of smooth muscle, and a layer of connective tissue.  The endothelial layer is involved in 
many physiological activities, including vasoconstriction and dilation, thrombosis, 
atherosclerosis, angiogenesis, inflammation, nitric oxide functions, as well as controlling 
passage of material into and out of the bloodstream.  The smooth muscle varies in thickness 
depending on the size and flow through the vessel and is responsible for vasoconstriction 
and vasodilation.  Nerves and lymphatic vessels are embedded in the outermost layer which 
also provides support for the blood vessels while attaching them to the surrounding tissue 
(Seeley et al., 2003). 
 Nitric oxide (NO), a small free radical molecule, is produced by a two step reaction 
involving the breakdown of L-arginine which is catalyzed by the enzyme nitric oxide 
synthase (NOS).  There are three isoforms of NOS: a neuronal form (nNOS), an inducible 
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Figure 1.4: Developing zebrafish hearts at 48 (A & B) and 96 (C & D) hours post-
fertilization exhibiting either typical looping after exposure to dimethyl sulfoxide (DMSO) 
(A & C) or lack of looping (B & D) due to exposure to 1 ng/ml (B) or 0.4  ng/ml (D) 
2,3,7,8-tetrachlorodibenzo-p-dioxin for 1 hour after fertilization.  V – ventricle; A – atrium 
(adapted from Antkiewicz et al., 2006 and Carney et al., 2006; reproduced with permission 
from Oxford University Press and the American Society for Pharmacology and 
Experimental Therapeutics). 
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form (iNOS), and an endothelial form (eNOS), the latter of which is responsible for much 
of the nitric oxide production in endothelial cells of the mammalian vasculature (Vallance 
and Chan, 2001; Swenson et al., 2005).  Nitric oxide has a wide array of effects on the 
mammalian vasculature, including vasodilatory, anti-thrombotic, anti-inflammatory, and 
anti-proliferative effects, as well as inhibitory effects on vasocontrictive agents such as 
angiotensin II (Vallance and Chan, 2001).   
 Prostanoids are also involved with many physiological functions including 
vasoconstriction and vasodilation (Breyer et al., 2001; Bos et al., 2004; Alfranca et al., 
2006).  There are five basic naturally occurring bioactive prostanoids, all of which are 
metabolites of arachidonic acid.  The five primary prostanoids are prostaglandins D-2 
(PGD2), E-2 (PGE2), and F-2 alpha (PGF2α), prostacyclin (PGI2), and thromboxane (TxA2) 
(Figure 1.5).  Each prostanoid has a specific G-protein-coupled receptor to which it binds 
with high affinity, although some cross reactivity is observed (Breyer et al., 2001; Bos et 
al., 2004; Alfranca et al., 2006).  PGF2α and thromboxane have been shown to cause 
constriction of blood vessels by activating pathways that increase smooth muscle 
intracellular calcium concentrations.  In contrast, PGD2 and PGI2 cause relaxation of blood 
vessels by stimulating pathways that result in increased cyclic adenosine monophosphate 
(cAMP) levels.  There are four receptor subtypes for PGE2 (EP1-4) that, when ligand bound, 
produce different effects.  When the EP1 receptor is activated, IP3 is generated, cell calcium 
concentrations increase, and vasoconstriction ensues.  EP2 and EP4 receptors signal 
pathways that activate the cAMP cascade in smooth muscle and cause vasodilation.  The 
EP3 receptor uses a pertussis toxin-sensitive G-protein-coupled mechanism to inhibit cAMP 
production, leading to vasoconstriction (Breyer et al., 2001; Bos et al., 2004; Alfranca et 
al., 2006).  Pharmacological agents such as indomethacin, naproxen, phenylbutazone, 
salicylates, and non-steroidal anti-inflammatory drugs (NSAIDs), all inhibit prostanoid 
synthesis (Curtis-Prior, 1976).  The effects of NSAIDs on vascular contractility will vary, 
but would depend on which prostanoid was being produced and which receptors were 
present on a particular vascular smooth muscle tissue. 
 Although they are products of different metabolic pathways, nitric oxide and 
prostaglandins have similar functions (Vassalle et al., 2003).  It is likely that there is some  
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Figure 1.5: Prostaglandin synthesis, platelet inhibition, and functions (adapted from Zha et 
al., 2004; reproduced with permission from Elsevier). 
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interaction between the two pathways and there is evidence that manipulation of one will 
affect the other (Vassalle et al., 2003).  Vassalle et al. (2003) demonstrated that PGE2 and 
6-keto-PGF1α (a stable metabolite of PGF2α) levels in human microvascular endothelial 
cells significantly increased when NO concentrations were increased.  This study also 
found that NO release was enhanced when cells were treated with indomethacin, but that 
PG levels did not increase after pharmacological inhibition of NOS.  It was suggested that 
indomethacin treatment increased intracellular calcium levels and that PGs helped regulate 
NOS activity by controlling the availability of calcium (Vassalle et al., 2003).  Conversely, 
a similar study in porcine aortic endothelial cells found that increased NO concentrations 
significantly decreased PGI2 production (Takeuchi et al., 2004).  This study also found that 
high NO concentrations inhibited calcium entry into the endothelium, which suggests that 
excessive NO limits PGI2 production by modifying the availability of calcium to 
phospholipase A2.  The exact influences that NO has on PG pathways, and vice versa, are 
still uncertain, but it is very clear that there is some interaction between them. 
 
 
1.7  Normal Mammalian Vasorelaxation 
 
 Normal mammalian vasorelaxation is regulated predominantly by nitric oxide.  
Endothelial cells lining blood vessels continuously produce nitric oxide to maintain and 
control vascular tone (Ignarro, 1990; Moncada et al., 1991), however prostaglandins may 
become the dominant influence on vasoactivity during inflammatory reactions.  Although 
prostaglandins are also being constitutively produced, their influence is less than nitric 
oxide.  Prostaglandins exist in a specific ratio but when synthesis is stimulated by hormones 
or inflammation, the ratio changes.  For example, PGI2, a potent vasodilator and platelet 
aggregation inhibitor, and TxA2, a vasoconstrictor and platelet aggregation stimulator, are 
constantly produced in a balance to help maintain blood flow and prevent clotting.  If the 
ratio of PGI2/TxA2 is high, vasodilation and anti-platelet activity are promoted.  Therefore, 
although prostaglandins are involved in many complex reactions, it is nitric oxide that is 
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responsible for most control of vascular tone in mammals (Ignarro, 1990; Moncada et al., 
1991). 
 
 
 1.8  Arterial Relaxation in Fish 
 
 Currently there is controversy surrounding the issue of arterial relaxation in fish.  
There is extensive information available on the structure and function of mammalian blood 
vessels but little is known regarding fish vasculature.  Studies on fish vasculature have 
shown that familiar mammalian vasoactive factors have opposite effects in fish.  Most 
notably, whereas acetylcholine dilates blood vessels in mammals, it contracts blood vessels 
in trout and dogfish (Farrell and Johansen, 1995).  Furthermore, although the specific 
regulators of vascular tone have not been conclusively identified, evidence indicates that 
cyclooxygenase-derived compounds primarily control vasoconstriction and dilation (Farrell 
and Johansen, 1995; Park et al., 2000).   
 Digital motion analysis has been used to monitor dorsal arteries and veins of 
zebrafish larvae and document responses to vasoactive compounds (Fritsche et al., 2000).  
This study found that the NO-donor sodium nitroprusside (SNP) induced vasodilation and 
the NOS-inhibitor, N-Nitro-L-Arginine Methyl Ester (L-NAME), induced vasoconstriction 
suggesting that the vasculature was influenced by endogenous NO.  Whole mount 
immunoreactivity assays for eNOS and nNOS identified the presence of eNOS in dorsal 
vein endothelial cells and the absence of nNOS in the peripheral tissues.  However, this 
must be interpreted with caution.  The investigators used polyclonal antibodies derived 
from the human and bovine eNOS genes and the rat nNOS gene (Fritsche et al., 2000).  
Cross-reactivity of fish tissue with polyclonal antibodies to eNOS does not definitively 
prove eNOS is present in fish and it is possible that the antibodies simply bound to similar, 
unspecified proteins.  In fact, a recent review has suggested that it is actually nNOS that is 
the source of NO in fish vasculature (Toda and Ayajiki., 2006).  Therefore, although 
evidence of a functional role of NOS in fish vasculature has been detected, evidence of 
eNOS is lacking. 
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 Tissue bath experiments have been used to expose piscine vessels to known 
mammalian endothelial-mediated vasorelaxants, several nitric oxide or NOS antagonists, 
various prostaglandins with COX and NOS inhibitors, and prostaglandin precursors with 
antagonists (Farrell and Johansen, 1995).  This study found that adenosine, adenosine 
diphosphate, adenosine triphosphate, and acetylcholine, which stimulate vasodilation in 
mammals, cause constriction of isolated fish vessels.  Thrombin and bradykinin had no 
effect and the prostaglandin precursors elicited a limited response.  Both PGE2 and PGI2 
produced strong relaxations in fish vessels and were found to completely antagonize 
precontraction from PGF2α.  Investigators could not identify a non-prostanoid compound 
that could be responsible for endothelium-mediated responses, suggesting that there were 
no biologically significant nitric oxide-mediated coronary artery responses in the species 
tested (Farrell and Johansen, 1995). 
 A second, similar study investigated the different responses in aorta from carp and 
rats exposed to vasoactive compounds (Park et al., 2000).  A donor-detector system in 
which a section of rat aorta was used as a relaxing factor donor and a section of carp aorta 
was hung in the same bath to detect responses to any substance released by the rat aorta.  
Individual vessels from the carp failed to react to both direct NO donors and indirect NO 
stimulating agents while all of these substances produced obvious vasorelaxation in rat 
aorta.  Increasing intracellular calcium using the calcium ionophore A23187 relaxed carp 
aorta, even in the presence of NOS inhibitor, L-NAME while indomethacin exposure and 
endothelium denudation inhibited the effects of A23187 (Park et al., 2000).  When the 
donor-detector system was reversed, it failed to find evidence of NO production in carp 
aorta.  From these results, the investigators suggested that a cyclooxygenase metabolite is 
responsible for endothelium-derived vasorelaxation in carp.  However, they could not 
completely rule out the possibility that the vessels produced NO or that these results are 
indicative of responses in all fish (Park et al., 2000).   
 The results of these studies do not provide substantial evidence to support nitric 
oxide relaxation in fish, despite the immunoreactivity observed in developing zebrafish 
(Fritsche et al., 2000).  There appears to be stronger evidence in support of a more 
biologically significant role for prostanoid-mediated relaxation in fish arteries (Farrell and 
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Johansen, 1995; Park et al., 2000).  Further studies are needed to clarify whether species 
differences, developmental differences, or artery bed differences have prevented a clear 
consensus on the relative roles of NO versus prostanoids in fish vasorelaxation.  
 
 
1.9  Zebrafish as a Model for AhR-Mediated Toxicity 
 
 Zebrafish are an efficient and useful model for toxicity studies.  Being small in size, 
it is easy to maintain large numbers of test animals with a small amount of space.  They 
produce high numbers of eggs and the embryos develop rapidly.  There is vast knowledge 
on the normal development of zebrafish and it is therefore possible to study what causes 
deviations from normal.  Relevant to this study, the progression of cardiovascular 
development and how TCDD affects this process has been well documented (see Goldstone 
and Stegeman, 2006 for review) (Figure 1.3).  The vasculature and circulation of the 
developing zebrafish has also been very well mapped out (Lawson and Weinstein, 2002).  
While the fish are in the early stages of development, they have transparent bodies which 
allow for the use of standard microscopy procedures to view the heart as it beats.  The 
Wellcome Trust Sanger Institute, in collaboration with three other laboratories, have 
completely sequenced and annotated the zebrafish genome providing a wealth of genetic 
and biological information.  Finally, zebrafish are reasonably sensitive to the AhR agonists 
TCDD and BaP, and have been used to characterize mechanisms of AhR-mediated 
developmental toxicity (Van Veld et al., 1997; Andreasen et al., 2002b; Bello et al., 2004; 
Antkiewicz et al., 2005), making them ideal models for this study. 
 
 
1.10  AhR and Cardiovascular Toxicity 
 
 Aryl hydrocarbon receptor-mediated toxicity in developing fish is characterized by 
yolk sac edema, hemorrhaging, severe cardiovascular deformities, impaired swim bladder 
16 
inflation, and craniofacial malformations (Cantrell et al., 1998; Andreasen et al., 2002b; 
Brinkworth et al., 2003; Karchner et al., 2005; Antkiewicz et al., 2006; Billiard et al., 
2006).  Lethality is usually due to cardiovascular defects and eventual complete circulation 
failure (Figure 1.3; Henry et al., 1997).  In normal vascular bed formation, the endothelial 
cells migrate and form the framework for the vasculature.  Once in place, the endothelium 
secretes chemical signals that initialize smooth muscle and connective tissue growth 
(Drake, 2003; Ferguson et al., 2005).  If the endothelial cells are damaged or unable to 
function properly, vascular bed development would be impaired.  It is proposed that 
increased CYP expression and activity increase expression of the anti-oxidant response 
element transcription factor called nuclear erythroid 2 p45-related factor 2 (NRF2), reactive 
oxygen species, and lipid membrane damage to produce symptoms of developmental AhR-
mediated toxicity (Andreasen et al., 2002a; Timme-Laragy et al., 2009).  However, the 
precise mechanism by which these events are linked to produce developmental AhR-
mediated cardiovascular deformities is not clear.  
 Currently, opinions are divided in the scientific community regarding whether the 
vasculature or the heart is the primary target of AhR-mediated cardiovascular toxicity.  
There are many studies which support the idea that the heart is the primary target for 
damage and the other symptoms, such as reduced blood flow and edema, are secondary to 
cardiac failure (Incardona et al., 2004; Antkiewicz et al., 2005; Carney et al., 2006).  For 
example, a poorly looped or unlooped heart is common after TCDD exposure (Teraoka et 
al., 2002; Antkiewicz et al., 2006; Carney et al., 2006; Incardona et al., 2006).  It is 
believed that this cardiac phenotype leads to decreased cardiac output resulting in decreased 
blood flow (Henry et al., 1997; Belair et al., 2001; Dong et al., 2002, 2004; Teraoka et al., 
2002).  There is also evidence to support the idea that cardiac dysfunction is a secondary 
effect.  Dioxin was observed to induce local circulation failure and reduce blood flow in the 
brain which preceded most other symptoms of TCDD toxicity including cardiac symptoms 
(Dong et al., 2002).  Another study reported that blood flow in the head and gills of 
developing zebrafish larvae was reduced before a reduction in heart rate (Andreasen et al., 
2002b).  Since vascular permeability increases during development after TCDD exposure 
(Cantrell et al., 1998; Guiney et al., 2000; Andreasen et al., 2002b), it is possible that the 
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vascular endothelium is a primary target or at least an independent target from the heart for 
TCDD-induced toxicity.  Damage to the endothelium could cause unregulated 
vasoconstriction or vasorelaxation, as well as potentially altering vascular bed 
development, which may explain some of the TCDD-induced cardiovascular toxicity. 
 
 
1.11 mRNA Expression as an Indicator of AhR Ligand Exposure 
 
 Induction of cytochrome P450 enzyme mRNA expression, particularly CYP1A, has 
traditionally been used as a biomarker for quantifying AhR agonist exposure but CYP1A 
may also be an indicator of effect.  Induction of the detoxification enzymes may not be the 
only cause of pathological effects seen with exposure (Handley-Goldstone et al., 2005; 
Carney et al., 2006; Teraoka et al., 2009).  Although mRNA may be increased, enzyme 
activity may not change (Wassenberg and Di Giulio, 2004; Timme-Laragy et al., 2007).  
However, there may be other genes whose expressions are increased which, in turn, 
produce pathological effects on the vasculature such as COX and iNOS.  Understanding the 
time-course of individual isozymes changed and the identity of all relevant genes that are 
altered after AhR agonist exposure is important in determining a more concise mechanism 
of AhR agonist toxic effects.  There is abundant evidence supporting a role for the AhR 
pathway in HAH and PAH toxicity, but the mechanism of toxicity remains unclear 
(Goldstone and Stegeman, 2006).  Comparing mRNA expression to the degree of varying 
developmental abnormalities may indicate phenotypes associated with specific AhR-
mediated alterations in mRNA.   Most mechanistic studies to date have used mortality or 
gross physical malformations elicited by very high levels of AhR agonists as endpoints for 
toxicity.  However, in order to dissect whether cardiac or vascular tissues are the primary 
target, and whether CYP1A is required, lower AhR agonist concentrations need to be used.  
Furthermore, it is unclear at what point the developmental defects will affect ultimate 
survival of the fish.  For example, evidence suggests even low level developmental PAH 
exposure can affect adult pink salmon returns for spawning (Heintz et al. 2000).  Therefore, 
mechanistic laboratory studies examining effects of developmental AhR agonists need to be 
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conducted using lower exposure concentrations as well as examining time points further in 
development before we can relate these toxicities to ultimate survival.  More importantly, 
due to the large number of genes potentially involved, phenotypic anchoring to these lower 
concentrations of AhR agonists with similar, overlapping mechanisms is critically needed 
to determine specific factors involved in AhR developmental toxicity. 
 
 
 1.12  Importance of Understanding Sublethal AhR Agonist Effects 
 
 There is ecological concern surrounding the possibility of sensitive fish species 
being exposed to AhR agonists.  There may be unforeseen reproductive consequences and 
an ultimate decline in fish survival (Heintz et al., 2000, 2007).  This poses potential 
environmental problems involving declining feral fish populations and decreasing game 
fish availability, but is also an economic problem for fisheries and aquaculture facilities.  
Very low, environmentally relevant concentrations may severely impact the quality of fish 
being produced and increase long-term mortality rates.  This would lead to increased costs 
associated with raising and housing fish, as well as a reduction in the product quality being 
turned out by these types of aquaculture facilities.  This thesis aims to provide new 
evidence to help better determine the mechanism of AhR agonist-induced toxicity which 
ultimately could be used for setting better regulations for these contaminants. 
 
 
1.13  Hypotheses 
 
The following were hypothesized for this thesis: 
 
1) Both BaP and TCDD, having similar and overlapping mechanisms of action, 
will induce similar responses in CYP and COX mRNA expression in 
zebrafish while the purported antagonists resveratrol and α-naphthoflavone 
will inhibit any changes induced by these agonists.   
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2) Changes in CYP and COX mRNA expression will be tissue-specific in adult 
zebrafish, differing between hepatic and arterial tissues. 
 
3)  Changes in CYP and COX mRNA expression will be different between 
tissues isolated from adult zebrafish and whole larvae homogenates. 
 
4)  The AhR-agonist-induced deformed cardiac phenotypes will correlate with 
alterations in expression of the same genes as vascular abnormalities. 
 
 
1.14  Research Objectives 
 
The following were the objectives for this thesis: 
 
1)  Method and primer development for CYP, COX, and NOS isoforms as well 
as optimization of in vivo and histological larval cardiovascular methods. 
 
2)  Determination of effects on tissue-specific mRNA expression in adult 
zebrafish induced by BaP and TCDD with and without the purported AhR 
antagonists.  
 
3)  Determination of effects on whole larval homogenate mRNA expression in 
zebrafish at 5 and 10 days post-fertilization after developmental exposure to 
BaP and TCDD with and without the purported AhR antagonists.  
 
4)  In vivo and histological analysis of various indicators of cardiovascular 
health and function in larvae at 10 days post-fertilization after 
developmental exposure to BaP and TCDD with and without purported AhR 
antagonists. 
 
5)  Perform correlation analysis of in vivo and histological markers of 
cardiovascular phenotype and function with mRNA expression changes after 
sublethal exposure to AhR ligands.   
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2.0  Method Development 
 
2.1  Primer Design and Validation 
 
  2.1.1  Choosing target genes 
 The CYP enzymes are commonly used to assess AhR agonist exposure.  While 
many of the CYP isoforms have been used in previous real-time reverse transcriptase 
polymerase chain reaction (rtrt-PCR) studies, the primers developed for these earlier 
experiments based on partial gene sequences were not suitable for the purpose of this thesis 
(Wang et al., 2006; Jönsson et al., 2007a, b; Timme-Laragy et al., 2007).  These older 
primers flanked regions that were approximately 100 basepairs (bp) in length, while the 
desired length of rtrt-PCR products for these experiments was between 150 and 200 bp. In 
the case of both CYP1C2 and the COX genes, primers have been published for these genes 
in zebrafish (Jönsson et al., 2007a; Ishikawa et al., 2007), but were not available at the time 
these experiments were initiated. Since these experiments were aimed at investigating 
molecular changes of CYP, COX, and NOS isoforms, primers needed to be designed for 
use in regular and real-time rt-PCR. 
 
  2.1.2  Primer development for CYP and COX isoforms 
 There were many programs involved in designing the primer pairs used in the real-
time polymerase chain reaction (PCR).  The process began with searching the National 
Center for Biotechnology Information nucleotide database for cDNA sequences of the 
genes of interest.  Sequences from two to four organisms other than zebrafish were 
necessary and tried to include sequences from humans, rats (Rattus norvegicus), dogs 
(Canis familiaris), and rainbow trout (Oncorhynchus mykiss).  These other animals were 
chosen because they are studied in the Weber laboratory and great care was taken to avoid 
effects from any possible contamination that may occur.  Multiple sequence alignments for 
the CYP isozymes were acquired through the use of DNAsmac (Toulouse, France), SeqAid 
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II (Manhattan, KS), and GeneDoc (http://www.psc.edu/biomed/genedoc).  The Geneious 
program (Auckland, New Zealand) was used for the initial sequence alignment for the 
COX isozymes.  After alignments, an online program called the DINAmelt server 
(http://dinamelt.bioinfo.rpi.edu/quikfold.php) showed the structure of the cDNA sequence 
under specified conditions.  The parameters chosen mimicked the annealing phase of a 
polymerase chain reaction.  These parameters were chosen in order to visualize any folding 
or hairpin loops that would occur in the sequence at the specific annealing temperature so 
that primers could be designed in regions where these structural changes did not occur.  
Once the desired regions were determined, Primer Designer (Cambridge, MA) was used to 
find at least ten primer pairs that would produce a PCR product around 200 basepairs in 
size.  Each primer was around 20 basepairs in length and had a predicted melting point 
around 60°C.   
 The GenBank and primer sequences were transferred into Amplify (Bill Engels, 
University of Wisconsin) and a virtual PCR was run with each primer pair to determine 
product size and verify that one fragment was isolated and amplified.  Amplify was also 
used to ensure that the primers designed for one gene did not target part of a sequence from 
a different gene.  Two primer pairs for each gene were then chosen (Table 2.1) and a 
regular PCR was run using liver and artery samples from control- (corn oil) and BaP-
treated (2 g/kg) zebrafish or larval samples from control- (DMSO) and TCDD-treated 
embryos.   
 
  2.1.3  Primer validation 
 The PCR products were run on a 1% agarose gel to confirm that the actual product 
obtained was of the predicted size in either adult tissue samples or whole larvae samples 
(Figure 2.1).  Artery and liver tissues were collected from adult zebrafish 24 hr after 
injection with either 1% v/w corn oil or 2 g/kg BaP.  Whole larvae were collected at 10 
days post-fertilization (dpf) after being exposed to either 0.5% v/v dimethyl sulfoxide 
(DMSO) or 10 ng/L TCDD.  Candidate primer pairs were chosen from these gels for real-
time rt-PCR.  In some cases, primer pairs amplified multiple fragments (primer pairs #6 
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and 11 in Table 2.1) and were no longer used.  Real-time rt-PCR analysis was performed in 
a Stratagene MX3005P QPCR system (VWR, Mississauga, Ontario, Canada) using SYBR 
Green qPCR Supermix (VWR).  The reaction was carried out with the same samples and 
the chosen primers to validate their effectiveness in rtrt-PCR.  The MxPro3005 software 
provides product melting point plots and a single melting point was used as a further 
confirmation that one product was produced for each primer pair.   
 
  2.1.4  Primer selection for CYP and COX isoforms 
 Of the primer pairs indicated in Table 2.1, # 2, 3, 5, 7, 9, 10, 13, and 14 were 
selected and used in all subsequent experiments shown in Table 2.2, as well as in Chapters 
3 and 4.  Primer efficiencies were calculated in the MxPro3005 software.  Briefly, serial 
dilutions of a single sample were used in real-time rt-PCR and a plot of sample dilution 
versus threshold value, that is, the cycle point at which amplification reaches a logarithmic 
phase, was plotted on a logarithmic scale.  The slope of the plot for each gene was used to 
calculate the efficiencies using the equation: 
   Efficiency (%) = (10(-1/slope) – 1) * 100     (Table 2.2).  
Generally, if the efficiencies of the primer pairs for the housekeeping and target genes 
differ by more than 5%, a two-fold difference could be observed as an artifact.  However, 
since all the efficiencies calculated were greater than 100% they are all binding at 
maximum capacity.  Therefore, the differences observed in primer pair efficiencies should 
be negligible.  Based on a single melting peak in rtrt-PCR, the presence of a single band on 
agarose gels and suitable rtrt-PCR efficiencies, the chosen primer pairs for CYP, COX, and 
G3PDH were considered to be suitable and PCR conditions considered to be optimized 
(Table 2.2). 
 
  2.1.5  Primer development for nitric oxide synthase isoforms 
 One of the original goals of this set of studies was to analyze nitric oxide synthase 
(NOS) expression, specifically, endothelial NOS (eNOS).  Personal correspondences with 
the Wellcome Trust Sanger Institute, the organization responsible for sequencing the  
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Table 2.1: Primers designed for each cytochrome P450 (CYP) and cyclooxygenase (COX) 
gene of interest and the expected fragment size. G3PDH was developed as a housekeeping 
gene. bp – basepairs 
 
Pair 
# 
Gene Forward Primer 
(5’ – 3’)  
Reverse Primer 
(5’ – 3’) 
Fragment 
Size 
1 CYP1A 698s - 
TTCGGGAAGATCGTGGGCAG 
932as - 
TTCGGTCTTCGCAGTGGTTGA 
208 bp 
2 CYP1A 745s - 
TGCCGATTTCATCCCTTTCC 
932as - 
TTCGGTCTTCGCAGTGGTTGA 
179 bp 
3 CYP1B1 1499s - 
AGACCTGACCACCAACGTGC 
1718as - 
ATGTTCCTACCAAGCTGTCC 
239 bp 
4 CYP1B1 1543s - 
GATGCATTGGAGAAGACG 
1727as - 
GAGTCTGAGATGTTCCTACC 
204 bp 
5 CYP1C1 1542s - 
CAGATTCCTGGATGAGAACG 
1765as - 
CCTCTGAGCTTGGCGGAGAT 
243 bp 
6 CYP1C1 1613s - 
AGCGGAGGTGCATTGGTGAG 
1794as - 
ATGCCGGTGAAACCAAGCCA 
201 bp 
7 CYP1C2 161s - 
GATAGCATGGCGCAGTCGGA 
322as - 
TTCCAACAAGCGGCCAAGCA 
181 bp 
8 COX-1 259s - 
GGGATCTGTGTTCGATATGG 
440as - 
CCAATCCCTGAGGAACGACC 
201 bp 
9 COX-1 829s - 
GGAGATTCTCTTGATCGCCA 
1031as - 
CTCACGAAGCCACAAGGTAG 
222 bp 
10 COX-2a 777s - 
CAGGTTGTGGATGGTGAGGT 
1029as - 
CACCAATCAGGATGAGACGA 
253 bp 
11 COX-2a 1341s - 
GCAGTTCAAGGAGTCGCTGT 
1522as - 
CACAAGAAGGCCAGGATACA 
201 bp 
12 COX-2b 567s - 
CCAGATCCTCAACGCACCAA 
764as - 
CCTCACCATCCAGAATCTGA 
217 bp 
13 COX-2b 1076s - 
GCTCAAGTTTGATCCCGAAC 
1265as - 
GCTGTTGACGCCATAATCTGT 
190 bp 
14 G3PDH 586s - 
AGCACTGTTCATGCCATCAC 
701as - 
TACTTTGCCTACAGCCTTGG 
135 bp 
 
 
Table 2.2: Primer efficiencies for primer pairs chosen for each gene of interest. 
 
Gene Primer Pair Slope Efficiency (%) 
CYP1A 2 -3.153 107.6 
CYP1B1 3 -3.321 100.0 
CYP1C1 5 -3.270 102.2 
CYP1C2 7 -3.148 107.8 
COX-1 9 -3.086 110.9 
COX-2a 10 -2.807 127.1 
COX-2b 13 -3.148 107.8 
G3PDH 14 -3.109 109.7 
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Figure 2.1: Agarose gel images of PCR fragments from primer validation for (A) 
cytochrome P450 (CYP) 1A, (B) CYP1B1, (C) CYP1C1, (D) CYP1C2, (E) 
cyclooxygenase (COX) 1, (F) COX-2a, (G) COX-2b, and (H) glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH).  Artery and liver tissues were collected from adult zebrafish 24 
hr after injection with either corn oil or 2 g/kg BaP.  Whole larvae were collected at 10 days 
post-fertilization (dpf) after being exposed for 96 hours to either 0.5% v/v dimethyl 
sulfoxide (DMSO) or 10 ng/L TCDD.  DNA ladder gradations are labeled in basepairs 
(bp).  BaP – benzo(a)pyrene; Con – control; TCDD – 2,3,7,8-tetrachlorodibenzo-p-dioxin; 
WL – whole larvae; NTC – no template control. 
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zebrafish genome, revealed that zebrafish do not have the eNOS gene. In support of this, a 
previous study failed to find evidence of the presence of a gene encoding for an eNOS 
homologue in the giant shovelnose ray (Rhinobatus typus) (Donald et al., 2004).  The two 
other isoforms of NOS that are known to be present in the zebrafish genome are inducible 
NOS (iNOS) and neuronal NOS (nNOS).  Since beginning this project, nNOS in fish has 
been postulated to fulfill much of the role played by eNOS in mammals (Toda and Ayajiki, 
2006).  However, iNOS was pursued in addition to nNOS because of its known role in 
inflammatory responses (Swenson et al., 2005) which may be relevant in AhR-mediated 
toxicity. Primers were developed following the previously described methods and 
validation was attempted (Table 2.3).   
 
2.1.6 iNOS and nNOS primer validation 
 During the initial primer development, there was only a partial cDNA sequence 
available for the iNOS gene.  The first primer pair (# 15) produced multiple products in 
real-time rt-PCR but the second pair (#16) appeared to amplify only one fragment based on 
a single melting peak.  However, the PCR product of the predicted size was only being 
produced in BaP-exposed arterial tissue while a second unknown fragment was also 
amplified in all the samples (Figure 2.2).  Three new primer pairs (#17-19) were later 
designed for iNOS after this and properly validated.  With these latter three primer pairs, 
each amplified a single product this time, but now all three fragments were larger than the 
predicted values (Figure 2.2).  Fragments from the first two iNOS primer pairs were sent 
out to be sequenced but sequencing was unsuccessful.  Of the two primer pairs designed for 
nNOS, one pair had multiple products and the other pair amplified fragments that were 
much smaller than the predicted fragments (Figure 2.3). At this point, due to time 
constraints and a shifting focus of this thesis to CYP and COX gene expression, resolution 
of the NOS primer problems was not further pursued, leaving this project without any 
successful NOS primers. Furthermore, although the zebrafish genome is completely 
sequenced, the annotation is lagging behind. Better success with designing NOS primers 
will be aided once these genes are annotated. 
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Table 2.3: Primers designed to amplify inducible and neuronal nitric oxide synthase 
(NOS).  bp – basepairs 
 
 
 
Pair 
# 
Gene Forward Primer 
(5’ – 3’) 
Reverse Primer 
(5’ – 3’) 
Fragment 
Size 
15 iNOS 55s - 
ACCAGACTGATCCATGGCTA 
193as - 
GCATAGAGAACAGTACAGCG 
158 bp 
16 iNOS 108s - 
GAGATGCAAGGTCAGCTTCA 
249as - 
GGTTGAGCATGGTGTTCAGT 
161 bp 
17 iNOS 832s - 
TGATGTGCTTCCACTAGTCC 
1035as - 
TGTGCCCATGTACCAGCCGT 
223 bp 
18 iNOS 1347s - 
CCGTCTATCATCAGGAGTTG 
1570as - 
TGGCAAAGCTCAGTGACTTC 
243 bp 
19 iNOS 2434s - 
TCCACCTTCACAAAGCCTGC 
2608as - 
TCTGACTCAGGATGAAGGCG 
194 bp 
20 nNOS 801s - 
CAACATGCCCACGGTGCTTA 
997as - 
CCTATGCAAACGTGCTCAGT 
216 bp 
21 nNOS 1040s - 
ACGCTCACGAACCAGATGAA 
1255as - 
ATTCGTCCCACACAGCGAGC 
235 bp 
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Figure 2.2: Agarose gel to validate primer pairs (pairs #15 – 19 from Table 2.3) for 
inducible nitric oxide synthase (iNOS).  DNA ladder gradations are labeled in basepairs 
(bp).  Artery and liver tissues were collected from adult zebrafish 24 hr after injection with 
either corn oil or 2 g/kg BaP.  Whole larvae were collected at 10 days post-fertilization 
(dpf) after being exposed to either 0.5% v/v dimethyl sulfoxide (DMSO) or 10 ng/L TCDD.  
BaP – benzo(a)pyrene; Con – control; NTC – no template control; TCDD – 2,3,7,8-
tetrachlorodibenzo-p-dioxin; WL – whole larvae. 
 
 
 
 
Figure 2.3: Agarose gel to validate primer pairs (#20-21 from Table 2.3) for neuronal nitric 
oxide synthase (nNOS).  DNA ladder gradations are labeled in basepairs (bp).  Whole 
larvae were collected at 10 days post-fertilization (dpf) after being exposed to either 0.5% 
v/v dimethyl sulfoxide (DMSO) or 10 ng/L TCDD.  Con – control; TCDD – 2,3,7,8-
tetrachlorodibenzo-p-dioxin; WL – whole larvae. 
 
 
 
28 
2.2  Determination of Suitable Vehicle for Adult Fish Injections 
 
 The initial solvent used in the adult zebrafish exposures was corn oil.  Various 
vegetable oils such as corn oil are commonly used as injection vehicles in toxicology 
studies because both BaP and TCDD are lipophilic , thus easily incorporate into the oil.  
The oil was expected to be rapidly absorbed by the fish after intraperitoneal (ip) injection.   
However, in preliminary experiments, a substantial amount of oil was still present in the 
abdominal cavity when the peritoneal cavity was opened during dissection 24 hours after 
the injection.  Since all of the oil was evidently not absorbed, it is very likely that all the 
BaP and TCDD were also not absorbed.  Because of this, it was important to find a 
different solvent that would ensure adequate toxicant delivery, but not exert toxicity by 
itself. An experiment comparing 24-hr acute vehicle toxicity after ip injection was 
performed (Table 2.4). TCDD and BaP were determined to be soluble at suitable 
concentrations for all vehicle solutions tested in Table 2.4. Based on these results, all 
further experiments examining effects of acute ip injection in adult zebrafish used solutions 
prepared in 0.5% (volume injected per weight of fish) DMSO.  
 
 
2.3  Optimizing Egg Rearing Conditions 
 
 Before actual experiments could be performed, exposure conditions and larval 
rearing conditions had to be optimized.  It was important to determine the ideal number of 
eggs that could be placed in each well of the exposure microplates.  Therefore, preliminary 
experiments were conducted, providing optimization as well as baseline values for larval 
mortalities and deformities to which all subsequent experiments could be compared.     
Five, six, and ten eggs were placed into wells in the same conditions that were to be 
used in the larval experiments (in Chapter 4) using uncontaminated water and reared until 
10 days post-fertilization (dpf).  Larvae were reared in 3 ml of dechlorinated system water 
per well with methylene blue added for the first 2 days.  Water was changed every day for  
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Table 2.4: Adult zebrafish exposure solvent mortalities and evidence of tissue damage 
around injection site 24 hr after intraperitoneal injection.  Statistical analysis was not 
performed since each mortality trial was only performed once or twice for each solvent.  
DMSO – dimethyl sulfoxide, μl/g – microliters of solvent injected per gram of fish.   
 
Injection Volume 
(μl/g) 
Solvent(s) Mortality
24 hrs 
Notes 
10 Toluene 0/6 Severe tissue necrosis around 
injection site 
10 1:4 
Toluene:DMSO 
4/6 High mortality 
10 2:3 
Toluene:DMSO 
3/6 
 
No initial tissue damage 
High mortality 
5 2:3 
Toluene:DMSO 
0/6 No observable deleterious effects 
10 DMSO 
 
0/6 Tissue necrosis around injection site 
5 DMSO 
 
0/6 No observable deleterious effects 
 
 
Table 2.5: Baseline (untreated) mortality rates at 5 and 10 days post-fertilization (dpf) and 
overall deformity rates of developing zebrafish incubated at different densities in 12-well 
microplates (mean ± SEM). n=12-65 wells/group 
 
Number of eggs 
per well 
% Mortality 
(5 dpf) 
% Mortality 
(10 dpf) 
% Deformities 
(10 dpf) 
5 5.2 ± 1.3 11.5 ± 2.1 3.8 ± 1.1 
6 4.0 ± 2.1 9.5 ± 5.6 4.0 ± 2.1 
10 8.0 ± 1.3 37.3 ± 3.9 6.9 ± 1.1 
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the first four days and then every second day thereafter.  Mortality was noted at 5 and 10 
dpf and overall deformities were noted for the total 10 days (Table 2.5).  Based on these 
rates, ten eggs per well was found to be too high a density but five and six eggs per well 
were comparable.  Therefore, 6 eggs per well was used in all subsequent experiments. 
 
 
2.4  Preliminary In vivo Cardiac Function Assessment 
 
  2.4.1  Introduction 
 Cardiac function in 10 dpf zebrafish larvae was hypothesized to respond to 
pharmacological challenges with acetylcholine (ACh) and norepinephrine (NE).  All 
previous toxicological studies in larval zebrafish have examined cardiac function only 
under unstimulated conditions (Henry et al., 1997; Andreasen et al., 2002a; Antkiewicz et 
al., 2005; Carney et al., 2006; Yamauchi et al., 2006). However, at least once basic 
biological study in developing zebrafish has utilized pharmacological tools to assess larval 
cardiovascular function (Park et al., 2000). Therefore, the goal of these preliminary 
experiments was to first assess how the conditions used for immobilizing larval zebrafish 
affected heart function under unstimulated conditions after developmental exposure to AhR 
ligands such as BaP and TCDD.  Second, the ability of heart rate in normal larvae to 
respond to exogenously applied norepinephrine and acetylcholine was also examined. 
 
  2.4.2  In vivo cardiac function measurements 
 The larvae were prepared in agarose according to methods described by Fritsche et 
al., (2000).  Briefly, zebrafish at 10 dpf were anesthetized in 50 mg/L ethyl 3-
aminobenzoate methanesulfonate (MS-222), a common fish and amphibian anesthetic 
which functions by blocking sodium channels (Wang et al., 1994).  The anesthetized larvae 
were embedded in a lateral position using low melt agarose dissolved in dechlorinated 
water with 50 mg/L MS-222.  The agarose was covered with 1 ml aerated dechlorinated 
water and fish imaged with an Olympus transilluminated upright microscope equipped 
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connected to a Canon HV20 high definition digital camcorder.  Larvae were imaged using 
brightfield illumination at 200x magnification.  The heart rate was imaged by recording 
near the trunk of the larvae. Heart rate in beats per minute (bpm) was calculated by 
counting the number of heart beats in 10 seconds and multiplying by 6.     
 The effects of the conditions used for immobilization on heart rate were assessed 
over a time period of 10 minutes.  The fish were embedded in agarose as described above 
and the beating heart was recorded for 10 minutes.  Heart rates between treatment groups 
were assessed at each time point using a repeated measures ANOVA. 
 Pharmacological challenges were carried out by adding 100 μl of either water (for 
baseline measurements), acetylcholine (1 and 10 mM), or norepinephrine (1 and 10 mM) to 
the water on top of the agarose.  Before addition of drug, a baseline recording was taken 
after addition of water and heart rate monitored for 1.5 minutes. Then, acetylcholine was 
added to produce a final concentration of 1 mM and effects monitored for 1.5 minutes. 
Finally, acetylcholine was added again to produce 10 mM and heart rate monitored for an 
additional 1.5 minutes.  Larvae were euthanized at this point and new larvae used to 
examine effects of norepinephrine in a similar manner. 
 
  2.4.3  Effects seen on in vivo cardiac function 
 The time course experiment indicated that there were no significant changes in 
unstimulated heart rate in the zebrafish larvae from each treatment group at 10 dpf over the 
10 minute observation period (Figure 2.4;  p>0.05 for time and treatment in repeated 
measures ANOVA).  There was also no difference observed between groups of larvae 
exposed developmentally to AhR ligands such as BaP and TCDD (Figure 2.4).  In normal 
larvae, no significant change occurred after the addition of either pharmacological agent 
ACh or NE at 10 dpf (Figure 2.5).   
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Figure 2.4: Time course of heart rates in larval zebrafish at 10 days post-fertilization (dpf) 
embedded in agarose from 0 to 10 minutes.  Results are mean ± SEM.  Larvae were 
exposed from fertilization until 4 dpf to aryl hydrocarbon receptor agonists benzo(a)pyrene 
(BaP; 5000 ng/L) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in 
combination with antagonists resveratrol (Res; 300 μg/L) and α-naphthoflavone (ANF; 100 
μg/L).  Data were analyzed using repeated measures ANOVAs, but no significant 
differences were detected with either time or treatment.  n=8-9 fish per treatment group. 
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Figure 2.5: Heart rates (beats per minute) of normal larval zebrafish at 10 days post-
fertilization after treatment with 1 mM and 10 mM norepinephrine or acetylcholine.  
Results are mean values.  Equivalent volumes of dechlorinated system water were added to 
the untreated fish instead of drug solution.  Arrows indicate addition of pharmacological 
agents at specified concentrations.   n=2 fish per treatment group. 
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2.4.4  Methodological challenges with in vivo analysis of cardiac 
function 
 It was apparent that the unstimulated heart rate did not significantly change over 
time and the method of immobilization was not lethal.  There also appeared to be no need 
for a stabilization period since the heart rate was fairly constant, therefore heart rate was 
measured immediately from the time of embedding for at least 2 minutes for all 
experiments in Chapter 4. 
 In contrast, the attempt to establish methods to challenge the larval zebrafish heart 
with drugs was a failure. There are a number of reasons that may have led to the inability to 
see drug-induced changes in heart rate using this method of measuring in vivo larval cardiac 
function.  The first reason is that the agarose may have been too thick and the drug did not 
permeate through to the fish.  The second reason is that the drugs permeated the agarose but 
were not absorbed in sufficient amounts by the larvae to produce an effect.  The third 
reason is that the drugs may actually have been oxidized or metabolized before they were 
able to cause an effect in the fish.  Therefore, all subsequent experiments measured only in 
vivo larval cardiac function under unstimulated conditions.  Previous successful 
experiments using pharmacological tools to manipulate cardiovascular function in agarose-
embedded larval zebrafish have used microinjection techniques, which appear to be 
necessary for success with this technique (Fritsche et al., 2000). 
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3.0  Hepatic and Vascular CYP and COX mRNA Expression in 
Adult Zebrafish Following Exposure to Benzo(a)pyrene 
and 2,3,7,8-Tetrachlorodibenzo-p-dioxin 
 
3.1  Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD or dioxin) are widespread environmental contaminants with increasing 
concentrations being found in aquatic areas near expanding urban centers or through global 
transport (Van Metre et al., 2000; Borghesi et al., 2008). Dioxin is both potent and 
persistent in the environment, causing a wide range of toxicities, including immunotoxicity, 
cardiotoxicity, and reproductive and developmental toxicity (Shertzer et al., 2004).  
Benzo(a)pyrene (BaP), a member of the PAH family, is not as persistent as TCDD and is 
rapidly metabolized into often unstable byproducts, such as epoxides, which have 
mutagenic and cytotoxic effects (Miller and Ramos, 2001). It is widely accepted that these 
compounds elicit toxic effects at least in part by activating the aryl hydrocarbon receptor 
(AhR) (Denison and Nagy, 2003).  While early life stages of fish species are exceedingly 
susceptible to PAH and TCDD toxicity (Peterson et al., 1993) with the cardiac and vascular 
systems being important targets (Henry et al., 1997; Dong et al., 2002), acute TCDD and 
PAH exposure has been reported to be relatively non-toxic in adult fish (Zodrow et al., 
2004; Wang et al., 2008). In contrast adult AhR agonist exposure in mammals is 
increasingly associated with deleterious effects on the vasculature with the endothelium 
being the primary target of these toxicants (Kopf et al., 2008; Oesterling et al., 2008).  
Thus, the acute vascular effects of AhR agonists are unknown in fish, but warrant 
investigation beginning with an examination of how important vascular and AhR-regulated 
gene expression is altered. 
 In order to investigate whether AhR mediates toxicological responses, a 
pharmacological approach using receptor antagonists could be used.  Although resveratrol 
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has been shown to antagonize AhR-mediated effects on CYP1A induction (Aluru and 
Vijayan, 2006), there have been no mechanistic studies involving this compound, therefore, 
it is unclear how it acts as an antagonist.  Alpha-naphthoflavone, on the other hand, has 
been shown to act as an antagonist via competitive receptor binding (Merchant et al., 1993) 
and via CYP1A substrate binding (Tassaneeyakul et al., 1993; Schaeffner et al., 2005), 
although the latter method of antagonism should not affect mRNA induction.  Therefore, 
these two antagonists will be used in combination with TCDD and BaP. 
AhR activation has been shown to affect the transcription of cytochrome P450 
(CYP) isozymes 1A and 1B1 (Nebert et al., 2000), as well as CYP1C1, a gene which 
appears to be exclusive to fish species (Godard et al., 2005; Wang et al., 2006; Jönsson et 
al., 2007a, b). Hepatic CYP1A is a common biomarker of AhR agonist exposure, but 
CYP1A expression significantly increases in multiple tissues after AhR agonist exposure 
including vascular endothelial cells in both mammalian and piscine species (Kerzee and 
Ramos, 2001; Dong et al., 2002; Teraoka et al., 2002). However, CYP1A expression 
increases to a much lesser extent in vascular smooth muscle (Kerzee and Ramos, 2001). 
Instead, smooth muscle CYP1B1 expression has been reported to be increased after AhR 
agonist exposure in the murine model (Kerzee and Ramos, 2001). In fish, CYP1B1 has 
been reported to have high constitutive expression in gill tissue, but may also increase after 
agonist exposure in liver, intestine, and gonad tissues (Willett et al., 2006). More recently, 
CYP1C1 expression was shown to be significantly increased by BaP and PCB-126 in heart, 
liver, and gill tissues of adult fish (Wang et al., 2006; Jönsson et al., 2007a, b). Similarly, 
expression of CYP1C1 and CYP1C2 were increased in larval zebrafish in an AhR-
dependent manner in most tissues (Godard et al., 2005; Jönsson et al., 2007b).  Thus, 
CYP1A expression appears consistently upregulated after AhR agonist exposure in most 
tissues previously examined except vascular smooth muscle, suggesting that tissue 
differences in AhR-mediated changes in gene expression need to be clarified. A goal of the 
current study was to examine gene expression changes specifically in vascular tissue 
because of the large number of vascular abnormalities after developmental AhR agonist 
exposure in fish (Dong et al., 2002; Teraoka et al., 2002; Billiard et al., 2006) and the 
increasing focus on AhR agonist effects in adult mammalian vascular tissue (Miller and 
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Ramos, 2001; Jang et al., 2007; Kopf et al., 2008; Oesterling et al., 2008). Although all 
highly perfused tissues such as liver contain vascular beds which would contribute to the 
overall gene expression profile, hepatocyte gene expression will predominate when this 
tissue is examined. Therefore, the current study compared the better characterized AhR-
mediated changes in hepatic gene expression with that in the relatively unknown 
mesenteric artery. 
Cyclooxygenases (COXs), also known as prostaglandin endoperoxide synthases, are 
involved in the conversion of arachidonic acid to prostaglandins. Zebrafish have three 
functional and constitutively expressed COX genes: COX-1, COX-2a, and COX-2b 
(Grosser et al., 2002; Ishikawa et al., 2007). The COX-1 transcripts have been identified in 
various adult zebrafish tissues, including gut, liver, gonad, heart and skeletal muscle while 
COX-2a expression was seen in the gills, gut, testis, heart and brain (Grosser et al., 2002; 
Ishikawa et al., 2007). Some COX-2b expression has been found in high levels in the gill, 
heart, and ovary, while lower expression levels were found in the kidney, gut, testis, eyes, 
and brain (Ishikawa et al., 2007). Knockdown of COX-1 in developing zebrafish has been 
shown to result in defects in vascular tube formation indicating a critical role in normal 
vascular development (Cha et al., 2005) while knockdown of COX-2a did not cause a 
discernable developmental phenotype (Grosser et al., 2002; Cha et al., 2005). Recently, 
COX-2a gene expression was found to be necessary and sufficient for mediating 
developmental TCDD toxicity, yet TCDD failed to increase COX-2a expression in whole 
larvae (Teraoka et al., 2009). In contrast, the effect of AhR agonists on COX-1 or COX-2b 
expression are not known in developing fish, while TCDD effects on all COX isoforms in 
adult fish are unknown.  Because of the importance of prostaglandins to the function of the 
adult fish cardiovascular system (Farrell and Johansen, 1995), the effect of AhR agonists on 
these genes was a focus of this study in adult fish. 
Therefore, it was hypothesized that acute AhR agonist exposure in adult fish would 
cause changes in gene expression that would differ between vascular and hepatic tissues. It 
was also hypothesized that the magnitude of CYP mRNA expression increase induced by 
AhR agonists would be greater in hepatic tissue while COX mRNA expression would 
increase to a greater extent in vascular tissue.  In order to investigate these hypotheses, 
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mRNA expression of CYP and COX isozymes were quantified in adult zebrafish liver and 
mesenteric artery 24-h after exposure to TCDD or BaP alone or in combination with the 
purported AhR antagonists resveratrol (Res) and α-naphthoflavone (ANF). 
 
 
3.2  Materials and methods 
 
3.2.1.  Chemicals 
Benzo(a)pyrene (B1760), 2,3,7,8-tetrachlorodibenzo-p-dioxin (10 μg/ml in toluene; 
48599), resveratrol (Res; R5010), α-naphthoflavone (ANF; N5757), dimethyl sulfoxide 
(DMSO; D5879) and ethyl 3-aminobenzoate methanesulfonate (MS-222; E10521) were all 
purchased from Sigma–Aldrich (Oakville, Ontario, Canada). The toluene in the TCDD 
stock was evaporated under nitrogen and then a dilute TCDD stock (2 μg/ml) was 
reconstituted in DMSO. All other chemical stocks for injection were dissolved directly in 
DMSO. 
 
3.2.2  Fish maintenance 
All fish housing and experimental procedures were approved by the Animal 
Research Ethics Board at the University of Saskatchewan in accordance with guidelines of 
the Canadian Council on Animal Care. Adult zebrafish were purchased from a local pet 
store and acclimated for 4 weeks in a static tank with particulate and charcoal filters, as 
well as ammonia biofilters prior to treatment.  Fish were maintained at 28.5 °C with a 
photoperiod of 14 h light and 10 h dark. They were kept on a diet of Nutrafin Max 
Complete Flake Food for Tropical Fish alternated with Hikari Bio-Pure frozen 
bloodworms. Food was withheld for 24 h prior to and after injection. 
 
3.2.3  Exposure 
Adult fish (0.5 – 1 g) were anaesthetized with 120 mg/L MS-222 until they were 
unresponsive to a tail pinch test. Fish (18 per treatment group) were injected with 5 μl of 
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test solution per gram of fish using an ultrafine needle on a 25-μl Hamilton syringe in the 
intraperitoneal cavity. Since arteries from multiple fish had to be pooled for a single 
sample, feasibility required a limited number of treatments to be examined. Therefore, 
single, acutely sublethal doses of AhR agonists and antagonists were chosen based on 
previous reports. Fish received a single injection of the vehicle, DMSO, or the following 
compounds alone or in combination: BaP (1 mg/kg; Wang et al., 2008), TCDD (20 μg/kg; 
Zodrow and Tanguay, 2003; Zodrow et al., 2004), Res (10 mg/kg–upper solubility limit of 
Res in vehicle; Aluru and Vijayan, 2006; Canistro et al., 2009) or ANF (50 mg/kg; Aluru 
and Vijayan, 2004). Following injections, fish were recovered individually in an aerated 
beaker before being transferred to a static exposure tank where all fish from a given 
treatment group were housed. No mortalities occurred in any of the treatment groups. Fish 
were euthanized 24 h after injection with an overdose of MS-222. A 24-h post-injection 
time was chosen in this study because it has been previously reported as the earliest near-
maximum point in mRNA expression after injection of AhR agonist in adult fish tissue 
(Chung-Davidson et al., 2004). Liver and mesenteric artery were removed, with a single 
liver being sufficient for one sample, while mesenteric arteries from 3 fish were pooled for 
each sample. 
 
3.2.4  Real-time rt-PCR 
Real-time rt-PCR was carried out to examine expression levels of CYP1A, 
CYP1B1, CYP1C1, CYP1C2, COX-1, COX-2a, and COX-2b. Total RNA was extracted 
from liver and artery samples with Trizol (Invitrogen, Burlington, Ontario, Canada) 
according to manufacturer’s specifications, then quantity (A260) and quality (A260:280; purity 
> 1.8 for all acceptable samples) assessed using a NanoDrop apparatus and software 
(Thermo Fisher Scientific).  cDNA templates were synthesized from total RNA with 
Superscript II reverse transcriptase (Invitrogen) and oligo (dT) primers. Real-time rt-PCR 
analysis was performed in a Stratagene MX3005P QPCR System (VWR, Mississauga, 
Ontario, Canada) using SYBR Green qPCR Supermix (VWR) with a reaction volume of 25 
μl. Glyceraldehyde-3-phosphate dehydrogenase (G3PDH) of zebrafish was used as a 
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housekeeping gene (internal control) and its expression was determined for every PCR run 
for every sample. Primers were designed in this laboratory based on GenBank zebrafish 
sequences using Geneious software (Biomatters Ltd) for multiple sequence alignments, 
DINAMelt (http://dinamelt.bioinfo.rpi.edu/quikfold,php) to predict melting profiles and 
Amplify (Bill Engels, University of Wisconsin) to run PCR simulations to predict product 
fragment size. The primer pairs for the genes of interest can be found with their accession 
numbers in Table 3.1. All primers were confirmed to produce only one gene product based 
on a single peak in the melting curve and a single band of the predicted size detected on 
agarose gels in preliminary studies. PCR efficiencies were determined to be ≥100% for all 
genes examined in the current study. 
 
3.2.5  Data and statistics 
All expression data for genes of interest were expressed as ΔΔCT values first using 
expression of the housekeeping gene (G3PDH) as an internal correction for expression of 
all genes of interest, followed by correction for control group expression of the gene of 
interest to calculate fold-change with treatment (Livak and Schmittgen, 2001). Results are 
presented as mean ± standard error of the mean (SEM). All data was log transformed to 
achieve normality (Shapiro–Wilk’s test) and homogeneity of variance (Levene’s test). 
Significant differences among groups were initially determined using a 2-way analysis of 
variance (ANOVA) with treatment and tissues as factors.  However, there were significant 
interactions between these two factors. Therefore, the analyses were split and separate 1-
way ANOVAs were run for each tissue, followed by Tukey’s posteriori tests as appropriate 
with p < 0.05 considered to be significantly different.  
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3.3  Results 
 
3.3.1  Effects of AhR agonists on mRNA expression 
Dioxin significantly increased (p < 0.05 in Tukey’s test after 1-way ANOVA) 
expression of hepatic CYP1A (104.8±21.1 fold-increase above control), CYP1C1 
(12.0±2.1), and COX-2b (2.2±0.3) mRNA as well as mesenteric artery CYP1A 
(120.6±22.9), CYP1B1 (5.2±1.2), CYP1C1 (28.7±6.3), CYP1C2 (6.7±0.9), and COX-1 
(2.5±0.3) mRNA (Figure 3.1). Benzo(a)pyrene significantly increased expression of COX-
1 (3.2±0.7) and COX-2b (1.6±0.1) in the liver, as well as expression of CYP1A (2.1±0.3), 
CYP1B1 (4.0±0.3), CYP1C1 (5.1±0.5), CYP1C2 (4.7±0.6), and COX-1 (2.3±0.3) in the 
mesenteric arteries (Figure 3.1). 
 
3.3.2  Effects of AhR antagonists on baseline mRNA expression 
Resveratrol had no significant effect on baseline mRNA expression of any of the 
genes examined in both hepatic and vascular tissue (Figure 3.2). On the other hand, ANF 
significantly increased CYP1A expression in both hepatic (61.8±8.5) and vascular tissue 
(11.1±1.5; Figure 3.2). Paradoxically, ANF significantly decreased CYP1B1 expression 
(0.3±0.04) in hepatic tissue, but increased CYP1B1 (5.9±0.3) in mesenteric artery (Figure 
3.2). Alpha-naphthoflavone alone also increased COX-1 expression in hepatic (3.5±0.7), 
but not mesenteric artery (Figure 3.2). Furthermore, ANF significantly increased 
mesenteric artery expression of CYP1C1 (4.6±0.6), CYP1C2 (6.6±1.4), COX-2a (3.5±0.8), 
and COX-2b (6.0±1.3; Figure 3.2).  
 
3.3.3  Effects of AhR antagonists on AhR agonist-induced mRNA 
expression  
Resveratrol had no significant effect on BaP-induced changes in mRNA expression of any 
of the genes examined in both hepatic and vascular tissues, while it did reduce TCDD-
induced CYP1C2 expression in the artery by 52% (Figure 3.3). In contrast, ANF 
significantly antagonized the effects of BaP-induced increases in hepatic CYP1B1 and  
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Table 3.1: cDNA target genes, GenBank accession numbers, and primers used for real-
time rt-PCR. 
 
 
 
Gene Primer Sequence (5’ – 3’)  
Accession 
Number 
Forward TGCCGATTTCATCCCTTTCC CYP1A 
  Reverse TTCGGTCTTCGCAGTGGTTGA
NM_131879  
  
Forward AGACCTGACCACCAACGTGC CYP1B1 
  Reverse ATGTTCCTACCAAGCTGTCC 
NM_001013267  
  
Forward AGCGGAGGTGCATTGGTGAG CYP1C1 
  Reverse ATGCCGGTGAAACCAAGCCA 
NM_001020610  
  
Forward GATAGCATGGCGCAGTCGGA CYP1C2 
  Reverse TTCCAACAAGCGGCCAAGCA 
NM_001114849  
  
Forward GGAGATTCTCTTGATCGCCA COX-1 
  Reverse CTCACGAAGCCACAAGGTAG 
NM_017043  
  
Forward CAGGTTGTGGATGGTGAGGT COX-2a 
  Reverse CACCAATCAGGATGAGACGA 
NM_153657  
  
Forward GCTCAAGTTTGATCCCGAAC COX-2b 
  Reverse GCTGTTGACGCCATAATCTGT
NM_001025504  
  
Forward AGCACTGTTCATGCCATCAC G3PDH 
  Reverse TACTTTGCCTACAGCCTTGG 
NM_001115114  
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Figure 3.1: (A) CYP1A, (B) CYP1B1, (C) CYP1C1, (D) CYP1C2, (E) COX-1, (F) COX-
2a, and (G) COX-2b mRNA expression (fold change relative to control levels) in adult 
zebrafish liver (black bars) and mesenteric artery (grey bars) tissues after 24-h exposure to 
aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP) and dioxin (TCDD). Results are 
mean ± SEM. Asterisks indicate statistically significant (p < 0.05, n = 4–6/treatment group) 
differences from control treatment values after 1-way ANOVA and Tukey’s posteriori test. 
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Figure 3.2: (A) CYP1A, (B) CYP1B1, (C) CYP1C1, (D) CYP1C2, (E) COX-1, (F) COX-
2a, and (G) COX-2b mRNA expression (fold change relative to control levels) in adult 
zebrafish liver (black bars) and mesenteric artery (grey bars) tissues after 24-h exposure to 
aryl hydrocarbon receptor antagonists resveratrol (Res) and α-naphthoflavone (ANF). 
Results are mean ± SEM.Asterisks indicate statistically significant (p < 0.05, n = 4–
6/treatment group) differences from control treatment values after 1-way ANOVA and 
Tukey’s posteriori test. 
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Figure 3.3: (A) CYP1A, (B) CYP1B1, (C) CYP1C1, (D) CYP1C2, (E) COX-1, (F) COX-
2a, and (G) COX-2b mRNA expression (fold change relative to control levels) in adult 
zebrafish liver (black bars) and mesenteric artery (grey bars) tissues after 24-h exposure to 
aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP) and dioxin (TCDD) in 
combination with antagonists resveratrol (Res) and α-naphthoflavone (ANF). Results are 
mean ± SEM. Asterisks indicate statistically significant (p < 0.05, n = 4–6/treatment group) 
differences from agonist alone treatment values after 1-way ANOVA and Tukey’s 
posteriori test. 
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COX-2b expression (reduced by 85% and 60%, respectively, compared to BaP 
alone; Fig. 3). Alpha-naphthoflavone also antagonized the effects of TCDD on hepatic 
CYP1B1, CYP1C1, COX-2a, and COX-2b expression (reduced by 69%, 74%, 56%, and 
58%, respectively compared to TCDD alone). However, in mesenteric artery, ANF had no 
significant antagonistic effects on BaP- or TCDD-induced changes in mRNA expression 
(Figure 3.3). 
 
 
3.4  Discussion 
 
The most intriguing finding of this study was that although ANF exhibited some 
antagonist action in adult zebrafish liver against genes other than CYP1A, it acted as an 
AhR agonist in arterial tissues from the same fish. While there have been numerous studies 
examining the effects of developmental AhR agonist exposure, few studies have examined 
effects of AhR agonist exposure during the adult stage in fish. Of those studies examining 
adult AhR agonist exposure, effects on CYP gene expression or enzyme activity have been 
reported only in fish liver and brain, although several mammalian studies have reported 
effects in vascular endothelial cells. In contrast, there are no previous reports of adult AhR 
agonist exposure effects in fish blood vessels. This study demonstrates that 24-h sublethal 
AhR agonist exposure elicits quite different expression patterns in fish mesenteric artery 
compared to liver. Finally, we have shown that AhR stimulation alters expression of the 
inducible zebrafish cyclooxygenase genes COX-2a and COX-2b, as well as the constitutive 
COX-1, all of which are important in adult fish cardiovascular function. 
Dioxin is an extremely potent AhR agonist that exerts more developmental toxicity 
and induces higher larval expression levels of CYP1A compared to the weaker AhR 
agonist, BaP (Ortiz-Delgado and Sarasquete, 2004), in agreement with the results of the 
current study in adult fish. Previous studies using aqueous exposures of the AhR agonist, 
BaP, have reported hepatic and vascular alterations in CYP1A or CYP1C1 expression 
(Ortiz-Delgado and Sarasquete, 2004; Wang et al., 2006). The current study failed to 
reproduce these effects of BaP on hepatic CYP expression, despite an exposure method (ip 
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injection) that guaranteed delivery of a high dose. However, since CYP enzyme expression 
was increased in mesenteric artery from the same fish, the BaP dose was successfully 
delivered in the current study. Instead, differences in time to respond to BaP or tissue 
sensitivity may be an explanation for failure to see changes in hepatic CYP expression after 
BaP injection. Several studies using a single, sub-lethal dose of TCDD higher than that 
used in the current study reported that CYP1A increased in multiple tissues of adult fish, 
including kidney, liver, gill, heart, gastrointestinal tract, and caudal fin, as well as in 
regenerating tissue (Zodrow et al., 2004). The current study, using a lower dose of TCDD, 
demonstrated that not just CYP1A expression was altered, but also CYP1B1, CYP1C1, 
CYP1C2, COX-1, and COX-2b. 
Differences in gene expression after TCDD versus BaP exposure in adult fish may 
be due to the ability of the fish to metabolize the parent compounds. Dioxin is not 
metabolized in the body and is, therefore, highly persistent and able to bioaccumulate in 
food chains (Piskorska-Pliszczynska et al., 1986). Since it is not broken down, it remains 
active in the system, constantly binding and activating the AhR, leading to the high 
expression levels observed in the current study. Benzo(a)pyrene, on the other hand, is 
easily metabolized and actually initiates its own metabolism by inducing CYP1A (Miller 
and Ramos, 2001). Therefore, one explanation for the relative lack of BaP effect on hepatic 
gene expression may be that the BaP, at the dose used in the current study, was rapidly 
metabolized in the adult fish, preventing sufficient AhR activation to change hepatic 
mRNA levels. However, since BaP was able to induce a small increase in arterial CYP1A 
gene expression, sufficient BaP must have reached this tissue to cause AhR activation. 
Previous studies have reported minimal or no induction of hepatic CYP1A protein and 
ethoxyresorufin-o-deethylase (EROD) activity after repeated ip injection with the same 
dose of BaP as the current study in other fish species (Wang et al., 2008). Therefore, 
mesenteric artery AhR may be more sensitive or responds faster to BaP than hepatic AhR 
in zebrafish at the time and dose examined in the current study. However, a full dose-
response and time-course experiment correlating BaP- to TCDD-induced effects on gene 
expression is necessary to confirm differences in tissue sensitivity to these compounds. 
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Resveratrol has been reported to be an effective AhR antagonist in rainbow trout 
(Oncorhynchus mykiss) hepatocyte cultures, reducing CYP1A mRNA after 24 h of 
exposure, but was also shown to act as a weak AhR agonist at doses lower than 10−8 M the 
same cultures (Aluru and Vijayan, 2006). Despite the successful use of resveratrol to 
abolish a variety of AhR induced effects (Casper et al., 1999) or to inhibit basal activity of 
several CYP enzymes in mice (Canistro et al., 2009), the efficacy of resveratrol as an AhR 
antagonist has yielded conflicting results when given in vivo rather than used in cell 
cultures or purified systems (Canistro et al., 2009). Since the current study failed to see any 
agonistic or antagonistic effects of resveratrol on AhR after ip injection in zebrafish, the in 
vivo efficacy of resveratrol is questionable. In fact, resveratrol is now known to interfere 
with a multitude of pathways, including COX-2 (Degner et al., 2009). Resveratrol has been 
shown to have an extremely low bioavailability in humans when given orally, therefore, the 
dose used, despite being a high one, may have been inadequate to produce systemic effects 
(Brown et al., 2009).  However, since only one dose (albeit a high dose) and time point was 
examined in the current study, antagonistic effects may have been missed and require 
further investigation.   
Alpha-naphthoflavone (ANF) has been used to effectively antagonize AhR-
mediated effects such as teratogenicity and apoptosis of neuronal cells in mammals (Jang et 
al., 2007; Kajta et al., 2009), as well as embryotoxicity and EROD activity in fish (Dong et 
al., 2002; Jos et al., 2007). However, ANF has been reported to act as either a weak agonist 
or an antagonist in mammalian cell lines, depending on the concentration used (Gasiewicz 
and Rucci, 1991). This agrees with the results of the current study in zebrafish and other 
studies in isolated rainbow trout hepatocytes (Aluru and Vijayan, 2004). Furthermore, ANF 
in combination with the AhR agonist beta-naphthoflavone (BNF) increases not only hepatic 
CYP1A protein expression (Aluru and Vijayan, 2004), but also promotes synergistic 
induction of CYP1A, CYP1B1, and CYP1C1 expression as well as synergistic increases in 
developmental deformities in larval fish (Billiard et al., 2006; Timme-Laragy et al., 2007). 
The novel observation in the current study that ANF by itself was able to increase 
expression of multiple CYP enzymes in vascular, but not hepatic tissue from the same fish 
may suggest that vascular tissue is more sensitive or responds faster to AhR agonists. 
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However, this possible difference in tissue sensitivity cannot be determined unless full 
dose-response and time-course of ANF effects are examined in future studies. 
Alternatively, although the current study did not provide any mechanistic evidence, ANF 
may produce tissue specific responses because it also activates AhR-independent 
mechanisms in mesenteric artery. 
The major focus of this study was to determine whether acute exposure to AhR 
agonists in adult fish causes potentially physiologically-relevant alterations in vascular 
gene expression.  Therefore, it stands to reason that genes other than CYP1A, such as 
COXs which play key roles in adult fish cardiovascular function, may be physiologically-
important. Our findings that vascular CYP1C1 mRNA expression was increased in a 
similar pattern, but not to the same magnitude, as CYP1A indicate that CYP1C1 could play 
a role in AhR agonist toxicity. The results of the current study confirmed the presence of 
COX-1 in hepatic tissues (Grosser et al., 2002; Ishikawa et al., 2007).  However, control 
group COX-2a and COX-2b transcripts were also detected with only COX-2b expression 
being increased by AhR agonist exposure. This could signify a more constitutive role of 
COX-2 isozymes in the liver, rather than the more commonly accepted inflammatory-
related role (Degner et al., 2009). In agreement with the current study, TCDD was reported 
to induce COX-2 expression in mouse hepatoma cells (Puga et al., 1997). Since the 
response pattern observed in the arteries was different and involved more genes compared 
to the liver, the vasculature should be further investigated as a target for AhR-mediated 
effects in adult fish. Furthermore, as BaP failed to induce hepatic CYP1A expression while 
still altering expression of other genes in vascular tissue, future studies should not rely 
solely on CYP1A as an indicator of AhR activity. 
Cyclooxygenase enzymes are reported to be required for normal blood vessel 
development in zebrafish (Cha et al., 2005) and for prostaglandin production which is of 
potential importance in fish vascular relaxation (Farrell and Johansen, 1995). Recent 
findings have indicated that COX-2a expression is necessary for TCDD-induced circulation 
failure in mesencephalic vein, but not arteries located in the trunk of the developing 
zebrafish (Teraoka et al., 2009). However, the same previous study failed to detect any 
increase in COX-2 isozymes by TCDD when expression was determined in whole larvae 
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(Teraoka et al., 2009). The current study also failed to detect significant increases in COX-
2a or COX-2b expression despite similar or larger magnitudes of increase compared to that 
observed in liver. Future studies must determine whether a Type II statistical error was 
made in the current study and clarify whether COX-2a and COX-2b increase in vascular 
tissue after AhR agonist exposure in adult fish. Therefore, the AhR agonist-induced 
alterations in COX-1 expression observed in the current study could interfere with vascular 
function similar to that reported after TCDD exposure in mammals (Kopf et al., 2008).  
Clearly the potential for physiologically-relevant effects would be even higher if COX-2 
isozymes are also affected. This study utilized whole mesenteric artery, making it unclear 
whether the expression changes are in the endothelium, smooth muscle, adventitia, or a 
combination. However, the increased vascular CYP1B1 expression is likely to be within 
the smooth muscle cells similar to that reported in mammals (Kerzee and Ramos, 2001). 
Regardless of which vascular cells are responsible for the increased expression of CYP or 
COX isozyme mRNA, clearly vascular tissue such as mesenteric artery is a responsive 
target for AhR agonist action in adult fish. Concurrent studies from this laboratory have 
found that vasorelaxant responses to exogenous prostaglandin E2 were unaltered in dorsal 
aorta after acute BaP exposure in rainbow trout, while responses to other vasorelaxing 
agents such as nitric oxide and hydrogen sulfide donors were altered (Goertzen and Weber, 
2008). However, whether the increased mRNA expression leads to alterations in COX 
protein levels, increased endogenous prostaglandin production and ultimately in 
biologically significant effects on cardiovascular function in fish needs to be confirmed in 
future experiments.  
In conclusion, neither resveratrol nor ANF appears to be suitable for use as AhR 
antagonists. Furthermore, there are important differences in acute responses in gene 
expression to both AhR agonists and antagonists between liver and arteries in adult 
zebrafish. The vascular-specific changes in gene expression will be linked to future studies 
examining alterations in cardiovascular function produced by acute AhR agonist exposure 
in adult fish. If confirmed in future studies, vascular responses to AhR agonists could 
negatively affect the ability of fish to regulate their blood pressure, repair blood vessels, 
impair the ability to swim, and ultimately reduce survivability of an individual fish. 
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4.0  Phenotypic Anchoring of Gene Expression After 
Developmental Exposure to Aryl Hydrocarbon Receptor 
Ligands in Zebrafish 
 
4.1  Introduction 
 
 Polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene (BaP) and 
halogenated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
are widespread environmental contaminants (Van Metre et al., 2000; Borghesi et al., 2008) 
that  cause a variety of reproductive, developmental, and cardiovascular toxicities (Shertzer 
et al., 2004; King Heiden et al., 2009). Activation of the aryl hydrocarbon receptor (AhR) is 
critical for these compounds to elicit many of their developmental toxicities (Denison and 
Nagy, 2003). Ligand binding to AhR stimulates translocation and dimerization of the 
receptor with the AhR nuclear translocator, resulting in transcriptional activation of the Ah 
gene battery (Nebert et al., 2000), including cytochrome P450 monooxygenase (CYP) 
enzymes, most notably CYP1A, CYP1B1, CYP1C1, and CYP1C2 (Nebert et al., 2000; 
Godard et al., 2005; Wang et al., 2006; Jönsson et al., 2007a, b).  Using knock down 
approaches with antisense morpholinos in zebrafish (Danio rerio), AHR2 and ARNT1 
appear to be necessary for TCDD-mediated developmental deformities (Antkiewicz et al., 
2006; Prasch et al., 2006).  Increased expression of CYP1A precedes cardiovascular 
toxicity (Cantrell et al., 1996; Guiney et al., 2000) and CYP1A knockdown may prevent 
pericardial edema and circulation failure (Teraoka et al., 2003) in TCDD-exposed fish. 
However, the necessity for CYP1A in TCDD-induced toxicity is equivocal since CYP1A 
knockdown in another study failed to prevent TCDD-induced developmental toxicity 
(Carney et al., 2004). Furthermore, developmental deformities persisted into the F1 
generation of zebrafish despite an absence of detectable CYP1A activity (King Heiden et 
al., 2009).  Finally, CYP1A knockdown may actually increase BaP and α-naphthoflavone 
(ANF)-mediated developmental deformities while CYP1B1 knockdown had no effect in 
zebrafish (Timme-Laragy et al., 2008). Thus, the role of CYP1A in developmental toxicity 
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requires clarification. Furthermore, expression of other CYP isoforms, specifically 
CYP1B1, CYP1C1, and CYP1C2 have been shown to significantly increase in 
cardiovascular tissue after AhR agonist exposure (Wang et al., 2006; Bugiak and Weber, 
2009). Therefore not only should other CYPs be investigated for their role in AhR-
mediated developmental toxicity, but other genes are known to be responsive to AhR 
ligands in cardiovascular tissue (Carney et al., 2004; Bugiak and Weber, 2009) and require 
further investigation.  
 Cyclooxygenases (COXs), also known as prostaglandin endoperoxide synthases, are 
involved in the conversion of arachidonic acid to prostaglandins.  Zebrafish have three 
functional COX genes: COX-1, COX-2a, and COX-2b (Grosser et al., 2002; Ishikawa et 
al., 2007). Constitutive COX-1 is widely expressed during larval development and is 
primarily responsible for prostaglandins required for gastrulation and segmentation (Cha et 
al., 2005, 2006; Pini et al., 2005). In contrast, COX-2 expression is responsible for 
inflammatory responses and may contribute to vascular tone (Tilley et al., 2001; Pini et al., 
2005).  A previous study from this laboratory reported that COX-1, COX-2a, and COX-2b 
mRNA levels are all significantly increased after acute exposure to AhR agonists in adult 
zebrafish (Bugiak and Weber, 2009).  Also, another recent study found that COX-2a was a 
necessary mediator of TCDD-induced reductions in mesencephalic vein blood flow, but not 
reductions in blood flow in the trunk of developing zebrafish (Teraoka et al., 2009).  Thus, 
while COX expression is emerging as an important factor in cardiovascular function and 
development (Farrell and Johansen, 1995; Teraoka et al., 2009), the relationship to AhR 
activity, the specific COX subtype(s) involved and subsequent phenotypic anchoring 
require further investigation. 
 Heart defects induced by AhR agonists, TCDD in particular, include decreased 
heart rate, decreased size, disruption in valve formation, and alterations in looping 
(Incardona et al., 2004; Antkiewicz et al., 2005; Mehta et al., 2008).  Pericardial edema 
increases pressure around the heart which may lead to a lack of heart looping (Teraoka et 
al., 2002).  The unlooped heart has a decrease in cardiac output potentially explaining the 
resulting decrease in a blood flow, a reported indication of vascular toxicity (Henry et al., 
1997; Belair et al., 2001; Dong et al., 2002, 2004; Teraoka et al., 2002).  Several studies 
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have noted cardiac changes prior to manifestation of circulatory effects (Teraoka et al., 
2002; Antkiewicz et al., 2005; Mehta et al., 2008), suggesting that cardiac changes are the 
primary developmental lesion and circulatory failure is secondary. If so, then AhR-
mediated changes in gene expression should show similar relationships to cardiac and 
vascular developmental defects. However, the relationship between AhR-mediated changes 
in cardiac gene expression and cardiac phenotype is still largely unknown (Handley-
Goldstone et al., 2005). Therefore, there is a need for further anchoring of the 
developmental cardiovascular phenotype with gene expression over a wide variety of 
conditions. 
 Whether a primary or secondary target of AhR-mediated developmental toxicity, 
early vascular development is a sensitive target of AhR-agonist-mediated toxicity as 
evidenced by regression failure of embryonic vascular structures, vascular permeability, 
declination of peripheral vascular bed health, and subsequent fin rot (Guiney et al., 1997; 
Henry et al., 1997; Andreasen et al., 2002a; Dong et al., 2004).  There is a critical window 
of time when developmental circulatory impairment can be induced from AhR agonist 
exposure which falls between 2 and 4 dpf (Belair et al., 2001).  This circulatory failure 
precedes TCDD-induced mortality (Henry et al., 1997) and reductions in red blood cell 
perfusion rates in the brain and trunk of developing zebrafish can be detected as early as 48 
hours post fertilization, several hours before completion of heart formation (Dong et al., 
2002; Teraoka et al., 2002).  Previous studies suggest that TCDD does not affect initial 
development of the vasculature, including size, number, and patterning of blood vessels, 
and it does not prevent initial blood flow to the trunk (Henry et al., 1997; Belair et al., 
2001).  However, peripheral vascular bed health and function decline (Henry et al., 1997), 
while embryonic yolk-associated structures, such as the common cardinal vein and vitelline 
vasculature, fail to regress in a normal fashion (Hornung et al., 1999; Bello et al., 2004; 
Goldstone and Stegeman, 2006). Developmental TCDD exposure has been reported to 
cause DNA damage and subsequent vascular cell death (Cantrell et al., 1996) which may be 
related to concomitant increases in vascular permeability (Guiney et al., 2000; Dong et al., 
2004). In contrast, blood flow is decreased after TCDD exposure and the vascular 
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endothelial cells appear distinctly sensitive to CYP1A induction (Guiney et al., 1997; 
Henry et al., 1997; Belair et al., 2001; Dong et al., 2002, 2004). 
 Although knockdown approaches using antisense morpholino oligonucleotides are 
perhaps the most common approach used for phenotypic anchoring of AhR-mediated 
developmental toxicity in larval zebrafish, contradictory results have occurred. Thus, the 
current study used a different approach for phenotypic anchoring. A variety of AhR ligands 
with slightly different, but overlapping mechanisms of action were used in order to dissect 
genes that were important for producing common aspects of a deformed phenotype. It was 
hypothesized that CYP mRNA expression would be correlated with cardiac defects while 
COX mRNA expression would be correlated with vascular alterations.  The objective of the 
current study was to first determine effects on CYP and COX gene expression patterns with 
different AhR ligands in larval zebrafish. Second, this study aimed to correlate these 
expression patterns with a variety of cardiovascular and developmental endpoints.  In order 
to carry out this objective, mRNA expression of CYP and COX isoforms were quantified in 
whole larvae 5 and 10 days post-fertilization (dpf) after exposure to TCDD and BaP alone 
or in combination with the purported AhR antagonists resveratrol (Res) or α-
naphthoflavone (ANF). 
 
 
4.2 Materials and Methods 
 
4.2.1  Chemicals 
 Benzo(a)pyrene (B1760), 2,3,7,8-tetrachlorodibenzo-p-dioxin (10 μg/ml in toluene; 
48599), resveratrol (R5010), α-naphthoflavone (N5757), dimethyl sulfoxide (DMSO, 
D5879) and ethyl 3-aminobenzoate methanesulfonate (MS-222; E10521) were all 
purchased from Sigma-Aldrich (Oakville, ON, Canada).  The toluene in the TCDD stock 
was evaporated under nitrogen and a 2 μg/ml TCDD stock was reconstituted in DMSO.  All 
other chemical stocks for exposures were dissolved directly in DMSO. 
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4.2.2  Fish Maintenance and Egg Exposures 
 All fish housing and experimental procedures were approved by the Animal 
Research Ethics Board at the University of Saskatchewan in accordance with guidelines of 
the Canadian Council on Animal Care.  Adult zebrafish were purchased from a local pet 
store and acclimated for at least four weeks in a flow-through tank.  Fish were maintained 
at 28.5°C with a photoperiod of 14h light and 10h dark.  They were kept on a diet of 
Nutrafin Max Complete Flake Food for Tropical Fish alternated with Hikari Bio-Pure 
frozen bloodworms.  Eight adult fish (three male, five female) were placed into each static 
breeding tank, eggs collected the following morning and placed in Petri dishes with system 
water containing 0.002% w/v methylene blue (Sigma-Aldrich, M9140) to wash.  Six 
washed eggs were placed per well of 12-well Falcon cell culture plates containing 3 ml of 
dechlorinated municipal water.   
 Eggs were statically exposed to AhR ligands for four days with daily renewal for a 
final concentration of 0.5% (v/v) of vehicle (DMSO).  Methylene blue was used as a 
fungicide in the water for the first two days of the exposures. After four days post-
fertilization (dpf), larvae were maintained in clean dechlorinated municipal water with 
renewal every two days until either 5 or 10 dpf.  The eggs were exposed to increasing 
nominal concentrations of BaP (5, 50, 500, 5000 ng/L), TCDD (1, 10, 100, 1000 ng/L), or 
vehicle control (0.5% DMSO) for the concentration-response experiment.  Subsequent 
experiments used TCDD and BaP alone or in combination with antagonists at the following 
concentrations: BaP (5000 ng/L), TCDD (1 ng/L), Res (300 μg/L – upper solubility limit of 
Res in vehicle), or ANF (100 μg/L; Billiard et al., 2006; Timme-Laragy et al., 2007).  At 5 
and 10 dpf, larvae were euthanized with an overdose of MS-222 and digital photographs 
taken under an Olympus dissecting microscope using darkfield illumination at 40x 
magnification. Photographs were used to quantify fork length (distance from snout to fork 
of tail) at 5 dpf and to note the incidence of deformities (craniofacial abnormalities, 
pericardial or yolk sac edema, spinal deformities) at both 5 and 10 dpf.     
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4.2.3  In vivo Cardiac Function Determination 
 A total of 81 fish, divided among nine treatment groups, were used for in vivo 
analysis.  Fish at 10 dpf were anesthetized by exposure to a solution of 50 mg/L MS-222 
for one minute (Fritsche et al., 2000).  The fish were then transferred to a small Petri dish 
where they were covered in a thin layer of 1% low-melt agarose (Sigma-Aldrich, A4018) 
containing 50 mg/L MS-222 in a lateral position.  The agarose was covered with 1 ml of 
aerated dechlorinated municipal water at room temperature containing 50 mg/L MS-222.  
The Petri dish was transferred to the stage of an Olympus transilluminated upright 
microscope equipped with a Canon HV20 high definition digital camcorder.  Larvae were 
imaged using brightfield illumination at 200x magnification and video footage of the 
beating heart was acquired for 10 minutes.  Heart rate (beats per minute or bpm) was 
calculated by counting the number of heart beats in 10 seconds at the beginning of every 
minute and multiplying by six.  Images were then exported from the video footage using 
Adobe Premiere Pro software (San Jose, CA) at 0, 2.5, 5, and 10 minutes. Ventricular 
cross-sectional areas at systole (sys) and diastole (dia) as well as heart length were 
measured using ImagePro Express software (Bethesda, MD). The percent change in cross-
sectional area (ΔCSA) was calculated as a measure of cardiac function using the following 
equation: ΔCSA  = ((dia-sys)/dia)*100%. 
 
4.2.4  Histological Analysis 
 A total of n=5 larvae per treatment group were used for histological determination 
of heart and vessel dimensions.  Fish at 10 dpf were euthanized with an overdose of MS-
222 before being transferred into neutral buffered formalin.  After 24 hours, fish were 
transferred to 70% ethanol and stored until histological analysis could be performed.  
Whole larvae were paraffin-embedded and sectioned (5 μm transverse sections) beginning 
at the anterior end of the eyes, collecting 250 serial sections, then stained with hematoxylin 
and eosin. Digital photomicrographs were obtained with a Zeiss AxioVert light microscope.  
Heart sections and sections for vascular analysis were photographed at 400x magnification.  
Six serial sections from the largest part of the ventricle were used to measure cardiac 
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dimensions and a single mean value from the sections used for each larva in statistical 
comparisons. Then 5 sections, each 25 μm apart, beginning near the anterior end of the 
stomach cavity, were used to measure the dimensions of the posterior cardinal vein and the 
dorsal artery and a single mean value for each vessel from the sections was used for each 
larva in statistical comparisons.  The inner and outer diameters of the ventricular chamber, 
posterior cardinal vein, and dorsal artery were measured using AxioVision software. Wall 
thicknesses were calculated as the difference between inner and outer diameters.     
 
4.2.5  Real-time rt-PCR 
At 5 dpf, 7 fish were pooled for each real-time rt-PCR sample, while at 10 dpf, 5 
fish were pooled for each sample. Real-time rt-PCR was carried out to examine expression 
levels of CYP1A, CYP1B1, CYP1C1, CYP1C2, COX-1, COX-2a, and COX-2b using 
previously described SYBR Green methods, primers, glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) as a housekeeping gene, and the ΔΔCt method to calculate fold-
expression changes compared to control (Bugiak and Weber, 2009).   
 
4.2.6  Data and Statistics 
   Results are presented as mean ± standard error of the mean (SEM).  Data was log-
transformed (gene expression data) where necessary to meet normality and variance 
assumptions. Differences among treatment groups were analyzed by separate 1-way 
ANOVAs followed by Tukey’s posteriori tests for most end-points.  The groups with zero 
variance in the incidence data (deformities and mortalities) necessitated the use of a 
different posteriori test (Fisher’s LSD) after 1-way ANOVA. Also, when data failed to 
meet normality assumptions despite a variety of transformations (fork length), a non-
parametric Kruskal-Wallis test was used followed by Kolmogorov-Smirnov posteriori tests.  
Pearson’s correlations were used to assess whether there were significant linear 
relationships between gene expression at 5 or 10 dpf and mortalities, deformities, 
cardiovascular functional end-points or histological end-points at 10 dpf. All relationships 
that had a r > 0.70 were graphed and p-values of the slope calculated.  Principal 
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components analysis (PCA) of mean values for each treatment group was used to further 
assess significant relationships among all the endpoints measured. All 5 dpf gene 
expression values were related to all 10 dpf phenotype end-points in initial PCA analyses, 
and then variables with the lowest correlations were eliminated until only those with high 
correlation (r > 0.65) to components 1 and 2 remained. 
 
 
4.3  Results 
 
4.3.1  Concentration-response phenotypes 
 Several deformities typical of developmental AhR agonist exposure such as 
pericardial and yolk-sac edema, craniofacial deformities, and spinal curvature were noted to 
occur (Figure 4.1) in a concentration-dependent manner in developing larvae at both 5 and 
10 dpf (Figure 4.2; data for 10 dpf shown). At 10 dpf, the deformity rate, but not the 
mortality rate remained unchanged after exposure to BaP concentrations ranging from 5 to 
5000 ng/L (Figure 4.2).  Higher BaP concentrations were not possible due to limited 
solubility.  Based on these results, the concentrations for the remaining experiments were 
chosen to ensure adequate survival until 10 dpf (5000 ng/L BaP and 1 ng/L TCDD). 
 
4.3.2  Mortality, Deformities, and Fork Length 
 After the concentration response experiments, single concentrations of AhR ligands 
alone and in combination were examined. The effects on mortality and deformities were 
similar but followed a different time-course for BaP and TCDD alone (Table 4.1). Both 
ANF and Res had no significant antagonistic effect on TCDD- and BaP-induced mortalities 
or deformities (Table 4.1). It is interesting to note that deformities were evident at 5 dpf in 
TCDD- and BaP/ANF-treated larvae, but that BaP or ANF treatment alone did not produce  
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Figure 4.1: Larval zebrafish at 10 day post-fertilization (dpf) representing normal 
development (A) and typical deformities (B and C) associated with developmental aryl 
hydrocarbon receptor agonist exposure. Images are from larvae treated with vehicle (A), 1 
ng/L 2,3,7,8-tetrachlorodibenzo-p-dioxin + 100 μg/L α-naphthoflavone (B), and 5000 ng/L 
benzo(a)pyrene + 100 μg/L α-naphthoflavone (C). Similar deformities to those shown here 
were noted at 5 dpf. All images were taken at 40x magnification. CFM – craniofacial 
malformation, YSE – yolk sac edema, SC – spinal curvature, PCE – pericardial edema 
 
 
 
 
Figure 4.2: Deformity (A) and mortality (B) rates at 10 days post-fertilization (dpf) after 
exposure to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; black points) or 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; white points) at increasing concentrations. 
N=12 wells per treatment group, each with 6 larvae/well. Results are mean ± SEM. 
Asterisks indicates significant differences from vehicle control deformity incidence of 3.1 ± 
2.1% or mortality incidence of 15.8 ± 3.5% at 10 dpf using Tukey’s posteriori test after 1-
way ANOVA. 
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visibly detectable deformities until 10 dpf (Table 4.1).  Furthermore, BaP, TCDD, and Res 
had no significant effect on fork length at 5 dpf (Figure 4.3).  However, ANF alone or in 
combination with BaP significantly decreased fork length when compared to the control 
group (Figure 4.3). 
 
4.3.3  Functional and Histological Analysis of the Heart 
 Using digital image analyses from videomicroscopy of live larvae at 10 dpf, AhR 
ligand exposure showed no significant effects on heart rate, ventricular length or heart 
function (indicated by percent change in ventricular cross-sectional area or ΔCSA) (Table 
4.2).  However, histological analysis of the heart at 10 dpf (Table 4.2; Figure 4.4) indicated 
that BaP in combination with ANF significantly reduced the ventricular chamber width, but 
not ventricular wall thickness. All other treatments were not significantly different 
compared to the control group for all cardiac end-points (Table 4.2). 
 
4.3.4  Histological Analysis of Dorsal Aorta and Posterior Cardinal 
Vein Dimensions 
 While ANF exposure had no antagonistic effects against TCDD, when combined 
with BaP, ANF significantly increased luminal diameter of both dorsal aorta and posterior 
cardinal vein compared to that of the control group (Table 4.3; Figure 4.4). No other 
treatment had a significant effect on blood vessel luminal diameter compared to control 
(Table 4.3). In contrast, no significant differences in wall thickness of both the dorsal aorta 
(DA) and posterior cardinal vein (PCV) were detected among all treatment groups in 10 dpf 
zebrafish (Table 4.3; Figure 4.4).     
 
4.3.5  Effects of AhR Ligands on mRNA Expression  
 At 5 dpf, TCDD, BaP, and ANF exposure significantly increased expression of 
CYP1A in whole larvae, while TCDD decreased CYP1C2 mRNA relative to control groups 
(Figure 4.5).  Resveratrol alone did not have a significant effect on mRNA expression of  
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Table 4.1: Mortality and deformity rates of developing zebrafish at 5 and 10 days post-
fertilization (dpf) after exposure to the aryl hydrocarbon receptor agonists benzo(a)pyrene 
(BaP; 5000 ng/L) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in 
combination with resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L). Data 
is expressed as mean ± SEM. n = 12 wells per group, each with 6 larvae per well. **p<0.01 
in Fisher’s LSD posteriori test after 1-way ANOVA.  Please note that deformity data at 10 
dpf is not cumulative deformities and is the deformity rate in the surviving larvae at 10 dpf.  
Presumably, severely deformed larvae have died prior to this time point, although this was 
not quantified.  A separate cohort with its own frequencies of mortality and deformities 
(also not cumulative) at 5 dpf is reported. 
 
 
 
5 dpf 10 dpf Treatment 
% Deformities % Mortality % Deformities  % Mortality  
Control 3.3 ± 2.3 3.5 ± 2.4 3.3 ± 2.3 1.4 ± 1.4 
Res 8.2 ± 2.6 2.1 ± 2.1 1.7 ± 1.7 5.0 ± 2.6 
ANF 14.9 ± 6.6 3.5 ± 2.4 5.0 ± 3.6 7.5 ± 4.5 
BaP 0.0 ± 0.0 0.0 ± 0.0 15.8 ± 5.8** 20.6 ± 5.8** 
BaP & Res 7.2 ± 3.1 4.4 ± 2.3 0.0 ± 0.0 2.8 ± 1.9 
BaP & ANF 31.0 ± 8.2** 5.8 ± 3.2 0.0 ± 0.0 21.4 ± 6.6** 
TCDD 26.1 ± 8.7** 0.0 ± 0.0 1.4 ± 1.4 6.5 ± 3.5 
TCDD & Res 15.1 ± 5.8 1.4 ± 1.4 2.8 ± 2.8 11.4 ± 4.5 
TCDD & ANF 22.5 ± 6.9** 1.4 ± 1.4 4.4 ± 3.1 10.0 ± 3.7 
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Table 4.2: Functional and morphological analyses of hearts in 10 days-post-fertilization (dpf) zebrafish determined using either 
in vivo microscopy or histological techniques. Larvae were exposed to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 
5000 ng/L) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with resveratrol (Res; 300 μg/L) or 
α-naphthoflavone (ANF; 100 μg/L).  ΔCSA = percent change in ventricular cross-sectional area from diastole to systole. Data 
are mean ± SEM. **p<0.01 compared to control in Tukey’s posteriori test after 1-way ANOVA. n=8-10 per group. 
 
 
 
 
 
 
 In vivo Microscopy Histology 
Treatment 
 
Heart Rate 
(beats/min) 
Ventricular 
Systolic Area 
(μm2) 
Ventricular 
Diastolic 
Area   
(μm2) 
Ventricular 
ΔCSA  
(%) 
Ventricular 
Length 
(μm) 
Ventricular 
Wall 
Thickness 
(μm) 
Ventricular 
Inner 
Diameter 
(μm) 
Control 134 ± 4 4970 ± 545 8451 ± 1611 36.3 ± 5.3 120 ± 6 7.18 ± 0.21 46.5 ± 2.2 
Res 129 ± 3 5105 ± 398 6949 ± 637 25.4 ± 3.4 115 ± 6 6.80 ± 0.36 39.8 ± 2.9 
ANF 139 ± 10 3267 ± 297 6012 ± 745 42.8 ± 4.3 97 ± 8 7.95 ± 0.33 42.6 ± 3.8 
BaP 135 ± 8 4882 ± 664 7284 ± 731 34.4 ± 3.0 113 ± 5 8.38 ± 0.41 42.5 ± 2.7 
BaP & Res 136 ± 5 4690 ± 320 7826 ± 448 38.9 ± 4.6 112 ± 4 6.78 ± 0.56 41.2 ± 2.1 
BaP & ANF 131 ± 13 4521 ± 786 7995 ± 1536 37.9 ± 6.0 103 ± 12 8.94 ± 0.34 24.9 ± 8.2** 
TCDD  143 ± 4 4415 ± 306 6635 ± 241 33.5 ± 3.5 101 ± 3 8.32 ± 0.18 39.7 ± 2.8 
TCDD & Res 154 ± 3 4294 ± 224 7028 ± 634 34.6 ± 3.8 104 ± 5 8.40 ± 0.22 37.2 ± 3.4 
TCDD & ANF 140 ± 6 3523 ± 230 5552 ± 317 35.8 ± 4.7 97 ± 5 8.53 ± 0.44 31.8 ± 5.1 
 
 
63
  
 
Table 4.3: Histological analysis of dorsal aorta and posterior cardinal vein in 10 days post-
fertilization (dpf) zebrafish.  Vessel wall thickness and luminal diameters after larvae were 
exposed to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 ng/L) or 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with antagonists 
resveratrol (Res; 300 μg/L) and α-naphthoflavone (ANF; 100 μg/L). Data are mean ± SEM. 
**p<0.01 compared to control in Tukey’s posteriori test after 1-way ANOVA. n=5 per 
group 
 
 
 
Dorsal Aorta Posterior Cardinal Vein Treatment 
Thickness 
(μm) 
Luminal 
Diameter (μm) 
Thickness 
(μm) 
Luminal 
Diameter (μm) 
Control 1.78 ± 0.02 7.34 ± 0.58 1.57 ± 0.08 7.05 ± 1.42 
Res 1.93 ± 0.13 7.86 ± 0.64 1.74 ± 0.06 6.57 ± 0.40 
ANF 1.80 ± 0.12 10.37 ± 1.05 1.49 ± 0.17 10.00 ± 0.88 
BaP 1.50 ± 0.10 9.60 ± 0.39 1.27 ± 0.08 9.81 ± 0.83 
BaP & Res 1.58 ± 0.06 6.57 ± 0.60 1.48 ± 0.09 8.91 ± 1.49 
BaP & ANF 1.77 ± 0.24 14.04 ± 2.99** 1.62 ± 0.15 13.52 ± 2.44** 
TCDD 1.61 ± 0.23 7.88 ± 0.81 1.34 ± 0.07 7.36 ± 0.78 
TCDD & Res 1.53 ± 0.05 8.16 ± 0.83 1.21 ± 0.09 5.36 ± 0.42 
TCDD & ANF 1.55 ± 0.07 8.34 ± 0.98 1.39 ± 0.16 9.40 ± 1.20 
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Figure 4.3: Fork length determined in zebrafish larvae at 5 days post-fertilization (dpf) 
from digital image analyses taken at 40x magnification. Data are mean ± SEM. Larvae 
were exposed to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 ng/L) or 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with 
resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L).  Different letters 
indicate statistically significant (p < 0.05) differences between treatment groups in 
Kolmogorov-Smirnov test after Kruskal Wallis non-parametric analysis.  n=29-49 
larvae/treatment group. 
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Figure 4.4: Representative histological cross sections stained with hematoxylin and eosin 
of whole zebrafish larvae showing the heart (A,B) and major blood vessels (C,D). Sections 
are from larvae exposed developmentally to vehicle (A, C), 5000 ng/L benzo(a)pyrene + 
100 μg/L α-naphthoflavone (B), and 1 ng/L 2,3,7,8-tetrachlorodibenzo-p-dioxin + 100 μg/L 
α-naphthoflavone (D). H – heart, DA – dorsal aorta, PCV – posterior cardinal vein. 
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any gene examined nor did it have any effect on BaP- or TCDD-induced mRNA expression 
changes.  In contrast, ANF caused an apparently additive increase in CYP1A expression 
with both BaP and TCDD, as well as an additive increase in CYP1C1 with TCDD rather 
than  exerting any antagonistic effect at 5 dpf (Figure 4.5). At 10 dpf, CYP1A expression 
remained significantly elevated compared to control in both BaP- and TCDD-treated 
groups (Figure 4.6).  However, no other genes examined remained significantly altered by 
these ligands compared to control groups at 10 dpf (Figure 4.6).  
 
4.3.6  Correlation and Principal Component Analyses 
 As an initial step in principal components analyses, all end-points measured in the 
previous figures were regressed against each other using mean values from each treatment 
group (± SEM) to uncover relationships among the end-points. Of particular interest was 
how mRNA expression of each gene analyzed at 5 dpf correlated with mortality and 
deformity rates at both 5 and 10 dpf (Table 4.4), or how 10 dpf gene expression was 
correlated with mortality and deformity rates at that same time.  All linear relationships 
with a Pearson correlation coefficient r ≥ 0.7 are shown (Figure 4.7).  At 5 dpf, CYP1C2 
expression was negatively and COX-1 expression was positively correlated to the 
deformity rate at 5 dpf (Figure 4.7).  Furthermore, COX-2b expression at 5 dpf was highly 
negatively correlated with the mortality rate at 10 dpf (Figure 4.7). The BaP/ANF co-
exposure group is indicated with an arrow in these figures because it was consistently a 
group that was on the extreme end of each relationship (Figure 4.7). 
 Gene expression at 10 dpf failed to show significant relationships to the functional 
and histological end-points measured at the same time point (Table 4.5). In contrast, 5 dpf 
gene expression showed several significant relationships to the 10 dpf phenotype (Figure 
4.8). Specifically, ventricular chamber width at 10 dpf was negatively correlated with 
CYP1A expression at 5 dpf, but positively correlated with CYP1C2 and COX-2a 
expression at 5 dpf.  The CYP1C1 expression at 5 dpf was negatively correlated with  
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Figure 4.5: CYP1A, CYP1B1, CYP1C1, CYP1C2, COX-1, COX-2a, and COX-2b mRNA 
expression (fold change relative to control levels) in pooled whole zebrafish larvae at 5 
days post-fertilization (dpf). Data are mean ± SEM. Larvae were exposed to aryl 
hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 ng/L) or 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with resveratrol 
(Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L).  Different letters indicate 
statistically significant (p < 0.05) differences between treatment groups in Tukey’s 
posteriori test after 1-way ANOVA.  In panels with no letters, no significant differences 
were detected among treatments. n=4-6 samples/treatment group. 
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Figure 4.6: CYP1A, CYP1B1, CYP1C1, CYP1C2, COX-1, COX-2a, and COX-2b mRNA 
expression (fold change relative to control levels) in pooled whole zebrafish larvae at 10 
days post-fertilization (dpf). Data are mean ± SEM. Larvae were exposed from fertilization 
until 4 dpf to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 ng/L) or 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with 
resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L).  Different letters 
indicate statistically significant (p < 0.05) differences between treatment groups in Tukey’s 
posteriori test after 1-way ANOVA. In panels with no letters, no significant differences 
were detected among treatments. n=4-6 samples/treatment group. 
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ventricular cross-sectional area at systole and diastole at 10 dpf, while CYP1A expression 
at 5 dpf was negatively correlated with ventricular length at 10 dpf. Overall, the BaP/ANF 
co-exposure group was observed to drive many of these linear relationships (BaP/ANF 
group indicated by arrows in Figure 4.8). 
 The gene expression levels of each gene at 5 and 10 dpf were correlated with 
histological measurements of the dorsal aorta and posterior cardinal vein at 10 dpf (Table 
4.6).  COX-2b mRNA expression at 5 dpf was strongly negatively correlated with luminal 
diameters of both dorsal aorta and posterior cardinal vein in developing zebrafish at 10 dpf 
(Figure 4.9).  Also, CYP1A expression at 10 dpf was negatively correlated with posterior 
cardinal vein wall thickness (Figure 4.9).  Again, the BaP/ANF co-exposure group appears 
to drive several of the linear relationships (Figure 4.9). 
 From the preceding correlation analyses, gene expression at 5 dpf correlated to 
many different aspects of phenotype at 10 dpf, while 10 dpf gene expression showed only 
one correlation to phenotype. Therefore, principal components analysis was performed on 
functional and morphological data at 10 dpf along with mRNA expression data for only 5 
dpf.  Principal components analysis provides a further examination of the relationships 
among multiple end-points, rather than being limited to just two end-points at a time as 
occurs with linear regressions. The top 12 end-points that explained the greatest variance 
among the groups (74% of the variability explained by components 1 and 2) were included 
in the final analysis (Table 4.7). The component loadings shown in Table 4.7 indicate the r-
value or strength of the end-point’s correlation to each component. Furthermore, the 
relationships of the end-points to each other can be inferred through their respective 
relationships to each component. In order to keep CYP1A in the final principal components 
analysis, the cut-off for inclusion of an end-point was relaxed to r = 0.65. The first 
component contained a cluster of end-points that all corresponded to ventricular 
morphology and blood vessel luminal diameter, while the second component contained 
only blood vessel wall thickness and heart rate for morphological and functional end-
points. Ventricular wall thickness and luminal diameter of both blood vessels as well as 
CYP1A expression were positively correlated to component 1 (Table 4.7). In contrast,  
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Table 4.4: Correlations between mRNA expression and mortality and deformity rates in 
zebrafish larvae at 5 and 10 dpf (Pearson correlation coefficient r).  
 
 
5 days post fertilization 10 days post fertilization 10 days post fertilization 
Genes Mortality Deformities Mortality Deformities Genes Mortality Deformities 
CYP1A 0.02 0.67 0.36 -0.14 CYP1A 0.11 -0.09 
CYP1B1 -0.12 -0.64 -0.47 0.23 CYP1B1 -0.16 -0.35 
CYP1C1 -0.31 -0.12 0.01 0.42 CYP1C1 -0.01 -0.37 
CYP1C2 -0.001 -0.83 -0.59 0.20 CYP1C2 -0.14 -0.38 
COX-1 0.37 0.77 0.25 -0.46 COX-1 0.33 0.14 
COX-2a -0.44 -0.63 -0.47 0.37 COX-2a -0.02 -0.10 
COX-2b -0.29 -0.45 -0.85 -0.15 
 
COX-2b -0.10 -0.29 
 
 
Table 4.5: Correlations between mRNA expression at 5 or 10 dpf and cardiac dimensions 
at 10 dpf measured using in vivo microscopy and histological techniques (Pearson 
correlation coefficient r). 
 
 
5 dpf Measurements at 10 dpf 
Genes Wall 
Thickness 
Inner 
Diameter 
Length Systolic 
Area 
Diastolic 
Area 
Ejection 
Fraction 
CYP1A 0.68 -0.73 -0.78 -0.67 -0.51 0.31 
CYP1B1 -0.44 0.69 0.17 -0.2 -0.15 0.15 
CYP1C1 0.22 0.08 -0.46 -0.72 -0.71 0.29 
CYP1C2 -0.67 0.74 0.55 0.16 0.22 0.1 
COX-1 0.44 -0.47 -0.56 -0.31 -0.04 0.35 
COX-2a -0.37 0.73 0.06 -0.25 -0.36 0.09 
COX-2b -0.66 0.67 0.38 0.14 -0.08 -0.37 
 
10 dpf Measurements at 10 dpf 
Genes Wall 
Thickness 
Inner 
Diameter 
Length Systolic 
Area 
Diastolic 
Area 
Ejection 
Fraction 
CYP1A 0.53 -0.36 -0.58 -0.45 -0.51 -0.02 
CYP1B1 0.14 -0.16 -0.14 0.02 0.07 0.04 
CYP1C1 0.32 -0.41 -0.46 -0.29 -0.24 0.06 
CYP1C2 0.2 -0.15 -0.15 0.06 0.1 -0.03 
COX-1 -0.13 -0.16 0.35 0.55 0.37 -0.2 
COX-2a -0.15 0.01 0.33 0.4 0.56 0.18 
COX-2b -0.1 -0.16 0.26 0.32 0.5 0.11 
 
 73
 
 
 
 
 
Table 4.6: Correlations between mRNA expression and dorsal aorta (DA) and posterior 
cardinal vein (PCV) dimensions as ascertained through histological and functional analysis 
at 10 dpf (Pearson correlation coefficient r) 
 
 
 
5 dpf Measurements at 10 dpf 
Dorsal Aorta Posterior Cardinal Vein Genes 
Thickness Inner 
Diameter 
Thickness Inner 
Diameter 
CYP1A -0.45 0.3 -0.38 0.31 
CYP1B1 0.04 -0.49 -0.16 -0.56 
CYP1C1 -0.32 -0.12 -0.41 -0.08 
CYP1C2 -0.08 -0.69 -0.02 -0.48 
COX-1 0.27 0.64 0.14 0.47 
COX-2a -0.27 -0.67 -0.42 -0.62 
COX-2b 0.26 -0.8 0.15 -0.83 
 
10 dpf Measurements at 10 dpf 
Dorsal Aorta Posterior Cardinal Vein Genes 
Thickness Inner 
Diameter 
Thickness Inner 
Diameter 
CYP1A -0.64 -0.17 -0.7 -0.31 
CYP1B1 -0.67 -0.42 -0.54 -0.31 
CYP1C1 -0.61 -0.22 -0.56 -0.26 
CYP1C2 -0.59 -0.36 -0.56 -0.39 
COX-1 -0.23 0.06 0.07 0.35 
COX-2a -0.58 -0.29 -0.29 0.02 
COX-2b -0.5 -0.31 -0.21 -0.06 
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Table 4.7: Principal components analysis of functional and morphological data from 10 dpf 
along with mRNA expression at 5 dpf in zebrafish exposed developmentally to aryl 
hydrocarbon receptor ligands.  The top 12 variables explaining the greatest variance were 
included in the final analysis and are listed in descending order along with correspondent 
component loadings.  Component loadings represent the strength of correlation of that end-
point to each component. Furthermore, the relationships of the variables to each other can 
be inferred through their respective relationships to each component. DA – dorsal aorta; 
PCV – posterior cardinal vein. 
 
 
 
 Component 1 Component 2
Total Variance Explained 44% 30% 
Variable Component Loadings 
Ventricular Thickness 0.903 0.204 
Ventricular Inner Diameter -0.837 0.252 
COX-2b mRNA at 5 dpf -0.827 0.280 
CYP1A mRNA at 5 dpf 0.771 0.390 
DA Inner Diameter 0.765 -0.515 
CYP1C2 mRNA at 5 dpf -0.764 0.328 
Ventricular Length -0.758 -0.314 
PCV Inner Diameter 0.680 -0.534 
Heart Rate 0.185 0.872 
PCV Thickness -0.282 -0.863 
DA Thickness -0.311 -0.751 
CYP1C1 mRNA at 5 dpf 0.141 0.624 
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Figure 4.7: Correlations with Pearson correlation coefficient r ≥ 0.7 are shown. 
Relationships between (A) CYP1C2 and (B) COX-1 mRNA expression at 5 days post-
fertilization (dpf) with deformity rates at 5 dpf or (C) COX-2b mRNA expression at 5 dpf 
with mortality at 10 dpf. Larvae were exposed to aryl hydrocarbon receptor agonists 
benzo(a)pyrene (BaP; 5000 ng/L) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) 
alone and in combination with resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 
μg/L).  Data are mean ± SEM.  Pearson correlation coefficients (r) and associated p values 
are indicated in the respective panels. 
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Figure 4.8: Correlations (Pearson correlation coefficient r ≥ 0.7) between (A) CYP1A, (C) 
CYP1C2, and (E) COX-2a mRNA expression at 5 days post-fertilization (dpf) with 
ventricular chamber width at 10 dpf, (B) CYP1C1 mRNA expression at 5 dpf with 2-
dimensional systolic area, (D) CYP1C1 mRNA expression at 5 dpf with 2-dimensional 
diastolic area, and (F) CYP1A mRNA expression at 5 dpf with heart length at 10 dpf after 
96 hour exposure to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 ng/L) 
or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination with 
resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L).  Data are mean ± SEM.  
Pearson correlation coefficients (r) and associated p values are indicated in the respective 
panels.  Arrows indicate BaP and ANF treatment group value. 
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Figure 4.9: Correlations (r ≥ 0.7) between (A) COX-2b mRNA expression at 5 days post-
fertilization (dpf) with dorsal aorta (DA) inner diameter at 10 dpf, (B) COX-2b mRNA 
expression at 5 dpf with posterior cardinal vein (PCV) inner diameter at 10 dpf, and (C) 
CYP1A mRNA expression at 10 dpf with posterior cardinal vein wall thickness at 10 dpf 
after 96 hour exposure to aryl hydrocarbon receptor agonists benzo(a)pyrene (BaP; 5000 
ng/L) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 ng/L) alone and in combination 
with antagonists resveratrol (Res; 300 μg/L) or α-naphthoflavone (ANF; 100 μg/L).  Data 
are mean ± SEM.  Pearson correlation coefficients (r) and associated p values are indicated 
in the respective panels.  Arrows indicate BaP and ANF treatment group value. 
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ventricular inner diameter and ventricular length, along with CYP1C2 and COX-2b 
expression were negatively correlated to component 1 (Table 4.7). For component 2, heart 
rate and CYP1C1 were positively correlated, while wall thickness of both blood vessels 
was inversely related to this component.  
 
 
4.4  Discussion 
 
 The first important finding of this study is that gene expression at 5 dpf correlates 
with morphological and functional phenotypes observed at 10 dpf in larval zebrafish 
exposed developmentally to AhR ligands. However, the most striking finding of this study 
is that expression of CYP1A is positively linked, while COX2b and CYP1C2 is negatively 
related to a deformed cardiac phenotype and increased blood vessel luminal diameter. In 
contrast, only one gene examined, CYP1C1, is negatively associated with blood vessel wall 
thickness, but is positively linked to heart rate.  While there have been numerous studies 
examining the effects of AhR agonists on larval gene expression and developmental 
deformities associated with AhR agonist exposure, few have attempted phenotypic 
anchoring by relating these two types of endpoints.  Finally, this study has shown that BaP 
and TCDD mediate similar changes, with differing efficacies, but that BaP co-treatment 
with ANF seems to produce an additive or possibly unique interaction that is worthy of 
further investigation.  
 While there have been many studies involving zebrafish and AhR-mediated 
developmental toxicity, most have used high doses of micro-injected AhR agonist, higher 
aqueous exposures or examined earlier time-points than the current study (Belair et al., 
2001; Andreasen et al., 2002a; Teraoka et al., 2002; Carney et al., 2004, 2006; Dong et al., 
2004; Antkiewicz et al., 2005; Mehta et al., 2008).  One of the main goals of this study was 
to assess morphological and functional end-points at a later point (10 dpf) than most 
studies. A recent study reported a threshold for prolonged zebrafish survival at 50 pg/ml 
TCDD aqueous exposure (King Heiden et al., 2009), which is close to the 1 ng/L (=1 
pg/ml) chosen based on the concentration-response experiment in the current study. The 
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previous study reported slightly higher incidences of deformities at comparable aqueous 
exposures than the current study (King Heiden et al., 2009). This difference in deformity 
rates may be due to the more detailed digital quantitation of craniofacial deformities and 
edema in the previous study compared to the current study. However, since the mortality 
rates are also much lower in the current study, the possibility that the actual aqueous TCDD 
concentrations achieved in the current study were lower than the nominal concentration 
cannot be excluded. Despite these differences in apparent TCDD sensitivity, the current 
study agrees well with this previous study on many points including the finding that the 
majority of mortalities occurred between 5 and 10 dpf. Furthermore, ANF exposure, alone 
or in combination with AhR agonists, caused significantly decreased fork length, agreeing 
with previous studies that also reported larval growth retardation after AhR agonist 
exposure (Prasch et al., 2003; King Heiden et al., 2009).    
 One of the most common cardiac effects reported in fish after developmental AhR 
agonist exposure is decreased heart rate or cardiac output (Henry et al., 1997; Andreasen et 
al., 2002a; Antkiewicz et al., 2005; Carney et al., 2006; Yamauchi et al., 2006).  However, 
the current study found no significant effect on heart rate or heart function. The reasons for 
this lack of observed change in heart function are not clear, but agree with the lower 
deformity and mortality rate also observed in the current study. The longer ventricle with 
thicker walls and thinner diameter observed in the current study after developmental co-
exposure to BaP/ANF is consistent with the unlooped heart phenotype reported in a 
previous TCDD study (Antkiewicz et al., 2005).  However, another study that used several 
PAHs instead reported dilated ventricular chambers and thinner walls in larval zebrafish 
(Incardona et al., 2004). The type of PAH used and the presence of additional AhR ligands 
are likely to be responsible for the observed differences in heart phenotype. The potent 
combination of BaP/ANF co-exposure produced a tube-like ventricular phenotype 
alongside impaired somatic growth (from Figure 4.4, panel D, skeletal muscle cells appear 
hypoplastic), suggesting these two processes may be related. In contrast, Res failed to exert 
any effect in the current study, neither antagonist or agonistic, agreeing with a previous 
study in adult zebrafish from this laboratory (Bugiak and Weber, 2009). Furthermore, the 
synergistic action of BaP/ANF co-exposure is similar to previous studies using other PAHs, 
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such as β-naphthoflavone, combined with ANF (Wassenberg and Di Giulio, 2004; Billiard 
et al., 2006; Timme-Laragy et al., 2007). Since the BaP/ANF group stood out in most 
correlations examined in the current study, it supports previous suggestions that there is 
synergistic activation of the same pro-oxidant mechanism (Timme-Laragy et al., 2009). 
While these previous studies have reported synergistic mRNA increases when ANF is 
combined with a PAH, CYP1A enzyme activity may actually be inhibited in these co-
exposures (Wassenberg and Di Giulio, 2004; Timme-Laragy et al., 2007). Thus, the 
combined exposure of these agents may be producing a unique mechanism of toxicity or 
may be simulating the mechanism of TCDD toxicity.      
 Peripheral vascular bed health and function have been reported to decline after 
developmental exposure to AhR agonists possibly secondary to decreased cardiac output 
(Henry et al., 1997; Incardona et al., 2004) while embryonic vascular structures fail to 
properly regress (Hornung et al. 1999; Bello et al., 2004; Goldstone and Stegeman, 2006).  
In the current study, increased luminal diameter of both dorsal aorta and posterior cardinal 
vein was observed only after co-exposure to BaP and ANF.  The failure to see similar blood 
vessel changes in TCDD and BaP-treated groups could again be due to the lower 
concentrations used in the current study or due to the fact that only large vessels were 
examined compared to much smaller vessels in previous studies.  The longer heart of 
smaller diameter observed in the current study would cause a decrease in cardiac output and 
should lead to thinner blood vessel walls since pressure is a major stimulus for increasing 
wall thickness. Instead, the principal components analysis suggests that heart rate, not the 
unlooped heart phenotype, is inversely related to vessel wall thickness.  Previous reports of 
AhR-mediated developmental deformities have instead indicated a reduction in blood flow 
occurs that eventually leads to vascular stasis (Guiney et al., 1997; Henry et al., 1997; 
Belair et al., 2001; Dong et al., 2002, 2004). The larger luminal diameter of the large 
conduit vessels observed in the current study would be consistent with this since dilation 
would slow blood flow velocity, particularly to peripheral vascular beds.   
 Dioxin and, to a lesser extent, BaP are both known agonists of the AhR (Ortiz-
Delgado and Sarasquete, 2004) and both induce increased expression of CYP1A (Guiney et 
al., 2000; Andreasen et al., 2002a; Teraoka et al., 2003; Billiard et al., 2006; Wang et al., 
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2006; Jönsson et al., 2007a, b; Bugiak and Weber, 2009), agreeing with the results of our 
current study.  In larvae, CYP1A expression has been reported to peak at 3 dpf after TCDD 
exposure and then decline (Prasch et al., 2003). The persistence of TCDD- and BaP-
induced CYP1A mRNA levels from 5 until 10 dpf in the current study could be explained 
by these agonists persisting in a reservoir within exposed tissues or another unknown 
reservoir within the exposure system (Belair et al., 2001).   
 Based on the results of the current study, CYP1C2 and COX-2b may have a 
protective effect against the CYP1A- and AhR-mediated developmental ventricular 
deformities and mortalities. Furthermore, CYP1C1 may be protective against AhR-
mediated decreases in heart rate and increases in large blood vessel diameter. Although 
COX-1 expression was not strongly related to either component in principal component 
analyses, it appears detrimental based on regression analyses in the current study.  Previous 
studies have shown that there are multiple genes responsive to AhR stimulation (Carney et 
al., 2006; Bugiak and Weber, 2009; Teraoka et al., 2009), but the normal physiological 
roles of many of these genes are still uncertain.  CYP1C1 and CYP1C2, for example, are 
still relatively new genes exclusive to fish and their roles in development are unknown 
(Godard et al., 2005; Wang et al., 2006; Jönsson et al., 2007a, b), but have been suggested 
previously to contribute to AhR-mediated developmental toxicity (Antkiewicz et al., 2006). 
In contrast, CYP1B1 is generally associated with smooth muscle (Kerzee and Ramos, 
2001), but its expression has been shown to increase in liver and vascular tissue after adult 
exposure to AhR agonists (Bugiak and Weber, 2009). However, there was no indication in 
the current study or other studies (Timme-Laragy et al., 2008; Yin et al., 2008) that 
CYP1B1 is required for AhR-mediated cardiovascular deformities.  
 Constitutive COX-1, widely expressed throughout developing zebrafish larvae (Pini 
et al., 2005), has been implicated in normal cardiac development (Cha et al., 2005, 2006) 
and has been shown to increase in response to AhR agonist exposure in adult zebrafish 
tissue (Bugiak and Weber, 2009).  However, the results of the current study are equivocal 
regarding a role for COX-1 in AhR-mediated developmental abnormalities since COX-1 
expression was positively related to deformities in the regression analyses, but failed to 
relate to the two components that explained most of the variation in principal component 
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analysis. Thus, the role of COX-1 in producing the AhR-mediated deformity phenotype, if 
any, requires clarification with further experiments.   
 The two COX-2 isoforms present in zebrafish are primarily involved in 
inflammatory responses (Tilley et al., 2001).  While knockdown of COX-2a protects 
against TCDD-induced alterations in blood flow in the mesencephalic vein, it did not 
protect against blood flow changes induced in the trunk, indicating that COX-2a may have 
a more important role in the head region of developing zebrafish (Teraoka et al., 2009). In 
the current study, COX-2a was positively correlated with ventricular inner diameter, but 
similar to COX-1, failed to show a relation to the top components in principal components 
analysis. This apparent discrepancy may be at least partially explained by the observation 
that COX-2a expression was not increased after TCDD exposure when measured in whole 
larvae (Bugiak and Weber, 2009; Teraoka et al., 2009). Instead, small local changes in 
COX-2a, particularly in cardiac and vascular tissue, may be key in mediating AhR 
developmental toxicity. In contrast, the results of the current study indicate a protective 
effect of COX-2b to keep large blood vessel diameter within normal limits. The specific 
prostaglandin(s) produced by COX-2b may be essential for proper vascular development or 
regulation (Cha et al., 2005, 2006).     
 In conclusion, it was confirmed that BaP and TCDD induce different patterns of 
mRNA expression while neither Res nor ANF appear to be suitable for AhR antagonism in 
vivo.  Concurrent exposure to BaP with ANF produces an additive toxic effect.  Alterations 
in mRNA expression in response to AhR agonists and antagonists differ between 5 and 10 
dpf with only CYP1A changes persisting to 10 dpf. Also, gene expression at 5 dpf, but not 
10 dpf correlated with phenotype at 10 dpf.  It was also shown that CYP1A, CYP1C1, 
CYP1C2, and COX-2a likely play a role in cardiac development while COX-2b may be 
important in vascular development of larval zebrafish.  However, causality cannot be 
inferred from the data in our study.  Further investigations using a variety of approaches 
should be carried out in order to ascertain the roles of these genes in AhR-induced toxicity 
in developing zebrafish.  Although there were slight differences in types and severity of 
deformities caused by different AhR ligands, some similarities in phenotype were observed. 
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This suggests that there may be a unifying mechanism for the common effects that has yet 
to be determined. 
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5.0  Overall Discussion and Conclusions 
 
 This thesis aimed to elucidate the effect of AhR ligands on CYP and COX gene 
expression as well as the development and function of the cardiovascular system in 
zebrafish.  After development of the necessary exposure, molecular and physiological 
methods needed for subsequent experiments, acute effects of AhR ligands in adult zebrafish 
were compared to developmental effects in larval zebrafish. 
 
 
5.1  Tissue-Specific Versus Whole Animal Homogenate mRNA 
Expression 
 
 There have been many studies looking at AhR agonist toxicity in adult zebrafish but 
many of these relied on mortality or reproductive success as endpoints (Giesy et al., 2002; 
Heiden et al., 2005; King Heiden et al., 2009).  There have been a few studies that looked at 
tissue-specific or whole larvae changes in mRNA expression of CYP enzymes (Godard et 
al., 2005; Wang et al., 2006), with a few more that have looked at changes in expression of 
different COX isoforms (Grosser et al., 2002; Cha et al., 2005; Teraoka et al., 2009). 
However, no study so far has examined AhR-mediated effects on both CYP and COX gene 
expression at the same time.  Furthermore, most previous studies examining AhR-mediated 
changes in gene expression in adult fish have looked at hepatic tissue (Incardona et al., 
2006; Jönsson et al., 2007a; Yu et al., 2008).  The few that have looked at changes in 
cardiovascular gene expression have examined mesencephalic vein (Dong et al., 2002, 
2004; Teraoka et al., 2009), rete mirabile (Schlezinger and Stegeman, 2000a; Garrick et al., 
2005), or heart (Carney et al., 2006).   
The larval experiments in this thesis identified changes in expression of multiple 
genes after exposure to AhR ligands, but these changes were based on a whole larval 
homogenate making it difficult to identify tissue-specific changes.  Comparing to gene 
expression changes in adult tissues could provide clues to indicate which tissues are being 
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affected during larval development.  For example, mRNA expression of all four CYP 
isoforms (1A, 1B1, 1C1, and 1C2) as well as COX-1 was increased in the mesenteric 
arteries of adult zebrafish after exposure to AhR agonists BaP and TCDD, while only 
CYP1A, CYP1C1, COX-1, and COX-2b were increased in hepatic tissue samples.  Thus, 
increased larval CYP1C2 observed in the larval study may be due to changes in vascular 
gene expression. Conversely, increased larval COX-2b may be due to changes in hepatic 
gene expression.  However, it is necessary to determine the ontogeny of the responsiveness 
of the receptor and gene battery in normal development to ensure that inducing these genes 
at an earlier time point does not have adverse effects on systems that are either unrelated to 
or secondarily affect the cardiovascular system.  It would be very interesting to perform 
laser-assisted microdissection and subsequent rtrt-PCR on the developing liver and artery 
tissue in the zebrafish. This is one method that would allow more direct comparison of 
tissue-specific changes in larvae versus adult fish after AhR agonist exposure. Additionally, 
incorporating more genes into this analysis, such as NOS isoforms, would increase the 
scope and understanding of AhR ligand-mediated toxicity. 
In contrast, CYP1A gene expression appeared to be increased after AhR agonist 
exposure in all tissues at all time points examined. Therefore, changes in CYP1A gene 
expression appear to lack tissue specificity.  Despite this apparent lack of tissue specificity, 
CYP1A expression showed a strong correlation to a deformed cardiac phenotype in larvae. 
This correlation along with previous studies showing an increase in cardiac CYP1A 
expression after AhR ligand exposure (Carney et al., 2006; Jönsson et al., 2007a) supports a 
critical role for this gene in mediating AhR ligand toxicity.  
 
 
5.2  Adult Effects Compared to Larval Effects 
 
 The concentrations and routes of exposure of the AhR ligands were quite different 
between the larval and adult exposures.  The adults were exposed to relatively higher 
concentrations of the compounds, but for a shorter amount of time than the larvae.  
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Intraperitoneal injections in adults also ensured greater delivery of the AhR ligands to the 
fish compared to lower aqueous exposure of embryos, a method where less toxicant is 
likely to be bioavailable. Based on mortality responses in the current and previous studies, 
even though adult zebrafish received higher doses, larvae are much more sensitive to the 
effects of the AhR agonist exposure (Henry et al., 1997; Cantrell et al., 1998; Andreasen et 
al., 2002b; Bello et al., 2004; Incardona et al., 2004; Antkiewicz et al., 2005).  Differences 
in bioavailability of the compounds used due to the routes of administration  probably 
contributed to the different responses observed at the different life stages.  With an ip 
injection, the compounds were likely metabolized in the liver before they reached effective 
levels systemically, whereas the aqueous exposure of the larvae allowed for gill uptake of 
the compounds, leading to rapid systemic distribution and effects before metabolism.  
There were no immediately observable physiological effects in adult fish after AhR ligand 
exposure despite changes in mRNA expression.  However, histological analysis was not 
performed in the adult fish study to determine the extent of injury to the heart and 
vasculature.  Measuring any cardiovascular physiological or morphological endpoint would 
have enabled the observed mRNA changes in adult fish to have greater biological meaning.     
The mRNA expression changes seen in the adult tissues were of a greater 
magnitude than those seen in the larvae.  Most notably, CYP1A expression in the adult 
hepatic and vascular tissues after exposure to TCDD was approximately 90- to 120-fold 
greater than the control group while in whole larvae CYP1A did not exceed a 16-fold 
difference above control groups at either time point examined.  The CYP1A induction in 
larval fish has been reported to peak at 72 hours after exposure to AhR agonists (Prasch et 
al., 2003), but the larval fish in this thesis were analyzed 24 and 144 hours after the 
cessation of exposures.  Possible explanations for lower larval expression changes after 
AhR agonist exposure could be due to either the earlier termination time-points or low 
exposure concentrations in the larval studies.  Developing a method to expose the adult 
zebrafish in an aqueous manner similar to the larval exposure would enable a more direct 
comparison of mRNA expression between the two stages of development.  Alternatively, 
the lower fold-induction of CYP1A in the larval studies in this thesis may instead be due to 
a developmental insensitivity to AhR-mediated pathways. The high mortality and 
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deformities observed after larval exposures argue against this latter possibility. A final 
possible explanation may be that CYP1A gene expression is not the primary mediator of 
AhR agonist toxicity. Further experiments examining adult responses to AhR agonists are 
needed to clarify these discrepancies. 
 
 
5.3  Predicted Consequences of Developmental AhR Agonist 
Exposure 
 
 Many of the effects observed after developmental AhR agonist exposure would be 
detrimental to further larval development, making it unlikely that the fish would survive to 
adulthood.  First, the gross deformities (i.e. spinal curvature, craniofacial deformities) 
would impede normal growth and development.  The craniofacial deformities alone would 
hinder proper feeding, directly affecting growth and survival.  The pericardial edema would 
put extensive pressure on the developing heart, potentially compounding heart 
malformations or at least promoting heart dysfunction.  Furthermore, yolk sac edema is 
accompanied by failure to resorb yolk (Hill et al., 2004), ultimately leading to mortality of 
the larvae.  Unlooped hearts would be lethal shortly after the time periods examined in this 
thesis (10 dpf), at least partially due to the decreased cardiac output reported in previous 
studies (King Heiden et al., 2009). However, even minor cardiac dysfunction would pose a 
problem later in the life of the fish as it may hamper the fish’s ability to swim after prey or 
avoid predation.  The findings of Heintz et al. (2000) support this idea because salmon 
exposed to low levels of PAHs in the laboratory, although grossly normal at the time of 
release into natural streams, returned to spawn in lower numbers than those that were 
reared in clean water.   
The more subtle effects on the vasculature, such as increasing vessel diameter 
observed in this thesis, would also become detrimental to the fish as development 
progressed, potentially contributing to circulation failure.  Dilated vessels could reduce 
blood pressure and particularly venous pressure sufficiently to impair ventricular filling. 
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Circulation failure has been reported to be inevitable after AhR agonist exposure (Henry et 
al., 1997), but this is likely dependent on higher exposure levels used in earlier mechanistic 
investigations (Walker and Peterson, 1994; Henry et al., 1997). At these high exposure 
levels, as circulation fails in peripheral vascular beds, the peripheral tissue begins to 
necrose and fins to deteriorate as a result of poor oxygen delivery.  At lower, more 
environmentally relevant exposures, impaired perfusion may not significantly affect a fish 
under normal conditions.  However, under stressful or high oxygen demand conditions such 
as hunting or predator avoidance, hypoxia caused by impaired perfusion may be severe 
enough to affect swim performance.  While the concentrations of AhR ligands used in this 
thesis are lower than most previous studies, it remains unclear how these effects would 
have progressed if the larvae had been allowed to develop further.  Therefore, examining 
lower concentrations of AhR agonist and growing the fish to adulthood is the next logical 
step in this line of investigation. 
 
 
5.4  Overall Conclusions 
 
 This study has shown that BaP and TCDD, while having similar mechanisms, 
induce different mRNA expression patterns in both adult and larval zebrafish.  Despite both 
compounds being known agonists of the AhR, there are likely other mechanisms of toxicity 
that are activated by these compounds.  It was not possible to elucidate the exact 
mechanism of AhR-mediated toxicity from this study.  Arteries from acutely exposed adult 
fish exhibited mRNA changes in a larger number of genes than the hepatic tissue, 
suggesting that arteries are more sensitive to AhR stimulation, particularly to ANF.  
Second, AhR ligand-induced mRNA changes precede physiological and morphological 
defects observed later in development.  The mRNA changes observed in larvae were not 
nearly as dramatic as those seen in the isolated adult tissues, but it was important to be able 
to anchor the mRNA expression to specific phenotypes.  Evidence from this thesis supports 
the hypothesis that CYP1A is a necessary mediator of AhR-induced toxicity.  However, the 
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COX-2 isozymes may also play a key role in cardiovascular function and development of 
zebrafish.   
 
 
5.5  Future Work 
 
 The results presented in this study are by no means conclusive.  With the 
availability of the entire sequenced and annotated genome of the zebrafish, morpholino 
studies are the next logical choice for experiments.  It would be naïve to assume that the 
genes analyzed here are the only ones involved in AhR-mediated toxicity.  However, it is 
reasonable to assume that some of these genes are very important in the mechanism of 
AhR-mediated toxicity.  Inhibiting these genes and analyzing the phenotypes that develop 
will provide more clues to the exact mechanism of AhR-mediated toxicity.     
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